Respiratory diseases principally affecting the interstitium, IBD co-morbidites

IBD_PULM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints J10_PULMEOS J10_OTHERINSTPULM	8029
6. Filter based on genotype QC (FinnGen only)	7084

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	IBD_PULM
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_PULMEOS\|J10_OTHERINSTPULM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Respiratory diseases principally affecting the interstitium, IBD co-morbidites based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7084	2886	4198
Unadjusted period prevalence (%)	1.56	1.02	1.92
Median age at first event (years)	69.83	67.27	71.59

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5642: Matched controls
39492

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.9

319.3

1271

2761

R05

ICD-10 Finland

Cough

3.6

317.3

1430

3388

S06.0

ICD-10 Finland

Concussion

12.6

312.9

385

228

NF1AA

NOMESCO Finland

Hip X-ray examination

10.3

310.6

432

315

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

95.1

308.3

222

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

4.1

307.7

2304

5733

M25.5

ICD-10 Finland

Pain in joint

4.0

307.7

1421

3078

L01BA01

ATC

methotrexate; systemic

77.0

307.7

322

M17.1

ICD-10 Finland

Other primary gonarthrosis

13.9

307.7

935

556

UGC12

NOMESCO Finland

Flexible bronchoscopy

16.7

307.7

1942

1201

G47.3

ICD-10 Finland

Sleep apnoea

21.9

307.7

1271

518

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

103.9

307.7

550

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

7.0

307.7

675

751

A10AE04

ATC

insulin glargine; parenteral

76.4

307.7

415

C07AB07

ATC

bisoprolol; oral

3.4

307.7

2961

9695

G56.0

ICD-10 Finland

Carpal tunnel syndrome

18.0

307.7

512

218

R4110

NOMESCO Finland

Physiotherapy

3.6

307.7

1781

4442

M13.9

ICD-10 Finland

Arthritis, unspecified

16.2

307.7

423

197

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

23.4

307.7

641

215

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

12.0

307.7

588

378

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

67.1

307.7

317

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

144.9

307.7

257

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

10.5

307.7

824

634

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

+∞

307.7

2858

L88

ICPC

Rheumatoid/seropositive arthritis

80.6

307.7

336

J18.9

ICD-10 Finland

Pneumonia, unspecified

8.6

307.7

2977

4524

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

6.3

307.7

1021

1329

GD1AA

NOMESCO Finland

Thorax X-ray examination

9.8

307.7

4090

8384

M79.6

ICD-10 Finland

Pain in limb

3.7

307.7

1999

5124

N02AX02

ATC

tramadol; systemic, rectal

4.7

307.7

2518

5828

M04AA01

ATC

allopurinol; systemic

5.4

307.7

876

1307

A07EC01

ATC

sulfasalazine; oral, rectal

23.9

307.7

587

191

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

921.4

307.7

482

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

54.8

307.7

2099

422

A10BK01

ATC

dapagliflozin; oral

40.6

307.7

344

R03BB04

ATC

tiotropium bromide; inhalant

5.6

307.7

1040

1545

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.2

307.7

1218

1676

GD1AD

NOMESCO Finland

Thorax CT examination

13.9

307.7

1220

769

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

43.9

307.7

869

163

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.9

307.7

1365

2971

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

53.6

307.7

256

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.8

307.7

956

1155

N02AJ06

ATC

codeine and paracetamol; systemic

4.0

307.7

2157

5313

M54.5

ICD-10 Finland

Low back pain

3.7

307.7

1577

3720

A10BK03

ATC

empagliflozin; oral

60.3

307.7

423

TPH04

NOMESCO Finland

Cathetrisation of vein

3.8

307.7

1485

3360

N03AX16

ATC

[U] pregabalin

7.0

307.7

1194

1453

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

9477.2

307.7

2401

Z3226

NOMESCO Finland

Physiotherapist

4.8

307.7

1094

1899

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

23.3

307.7

582

194

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

44.6

307.7

296

M16.1

ICD-10 Finland

Other primary coxarthrosis

25.0

307.7

479

146

A10BH01

ATC

sitagliptin; oral

1086.5

307.7

427

AA1AD

NOMESCO Finland

CT of head and brain

5.9

307.7

1488

2254

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

7.8

307.7

636

633

R02

ICPC

Shortness of breath/dyspnoea

5.7

307.7

1041

1514

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.5

307.7

738

558

A10BA02

ATC

metformin; oral

57.9

307.7

1353

214

XG410

NOMESCO Finland

Flow-volume spirometry

21.4

307.7

767

288

Z01.8

ICD-10 Finland

Other specified special examinations

4.4

307.7

1411

2793

A10BB12

ATC

glimepiride; oral

94.3

307.7

245

C03CA01

ATC

furosemide; systemic

5.7

307.7

2376

4496

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

14.0

307.7

597

331

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

16.8

307.7

544

249

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

120.1

307.7

543

A02BC02

ATC

pantoprazole; systemic

5.2

307.7

4262

14658

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

11.0

307.7

486

335

B01AC04

ATC

clopidogrel; oral

4.8

307.7

951

1595

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.9

307.7

1603

3616

L04AX03

ATC

methotrexate; systemic

21.2

307.7

738

278

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.3

307.7

1501

2531

L04AA06

ATC

mycophenolic acid; systemic

50.5

307.7

501

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.3

307.7

1916

4260

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

261.1

307.7

630

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

14.9

307.7

843

461

A28

ICPC

Limited function/disability NOS

4.7

307.7

1007

1756

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

501

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

209.5

307.7

467

R03AC02

ATC

salbutamol; inhalant

4.6

307.7

3608

10939

J01MA12

ATC

levofloxacin; systemic

4.0

307.7

1413

3056

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.4

307.7

2720

5814

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

9.3

307.7

808

694

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

60.1

307.7

278

N02BE01

ATC

paracetamol; systemic, rectal

4.0

307.7

4754

22702

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.4

307.7

1707

3573

M05BA04

ATC

alendronic acid; oral

7.7

307.7

802

827

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

15272.2

307.7

1584

M19.0

ICD-10 Finland

Primary arthrosis of other joints

14.9

307.7

415

209

J01MA14

ATC

moxifloxacin; systemic

6.3

307.7

904

1166

N03AX12

ATC

[U] gabapentin; oral

12.2

307.7

763

498

E11

ICD-10 Finland

Type 2 diabetes mellitus

22.7

307.7

676

235

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

49.8

307.7

1274

230

TGC00

NOMESCO Finland

Bronchial lavation

62.5

307.7

1320

192

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

8.5

307.7

875

831

J96.1

ICD-10 Finland

Chronic respiratory failure

14.7

307.7

466

240

R06.0

ICD-10 Finland

Dyspnoea

7.7

307.7

2453

3593

A10AB05

ATC

insulin aspart; parenteral

64.6

307.7

403

M48.0

ICD-10 Finland

Spinal stenosis

50.6

307.7

636

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

4.6

307.7

1338

2483

L28

ICPC

Limited function/disability (L)

5.4

307.7

968

1452

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.2

307.7

1143

2229

H02AB06

ATC

prednisolone; systemic

11.6

307.7

4302

8584

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

169.9

307.7

255

R5140

NOMESCO Finland

Monitoring the use of the aid

16.2

307.7

708

346

P01BA02

ATC

hydroxychloroquine; oral

60.6

307.7

804

108

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

44.3

307.7

449

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

18.9

307.7

585

240

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

58.6

307.7

1302

201

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

493

103

Kela drug reimbursment

Diabetes, insulin-treated

218.7

307.7

1355

T90

ICPC

Diabetes non-insulin dependent

23.6

307.7

1227

459

SPAT1262

SPAT

Handing over of treatment supplies

8.8

307.7

958

898

L04AX01

ATC

azathioprine; systemic

17.3

307.7

626

283

215

Kela drug reimbursment

Diabetes, non-insulin-treated

397.8

307.7

1207

A10AC01

ATC

insulin (human); parenteral

60.2

307.7

422

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

35.9

307.7

406

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

12.0

307.7

2097

1855

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

51.3

307.7

370

I50.9

ICD-10 Finland

Heart failure, unspecified

5.5

307.7

1134

1714

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1121.5

307.7

572

J45.9

ICD-10 Finland

Asthma, unspecified

4.9

307.7

1344

2377

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.4

307.2

1534

3882

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.4

306.5

1554

3971

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

303.6

332

C10AA01

ATC

simvastatin; oral

2.9

300.6

2312

7559

N02BF01

ATC

gabapentin; oral

9.3

298.6

445

360

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

5.2

297.3

764

1157

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.7

297.0

1273

2901

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.1

295.8

1034

2030

WX320

NOMESCO Finland

Spinalanesthesy

3.8

294.1

1189

2599

J45.1

ICD-10 Finland

Nonallergic asthma

6.6

292.7

578

669

R03AK08

ATC

formoterol and beclometasone; inhalant

9.4

289.5

429

344

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

19.5

286.8

287

108

A02BC05

ATC

esomeprazole; systemic

2.9

285.3

2187

7094

L04AX05

ATC

pirfenidone; oral

+∞

285.1

312

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

12.1

280.7

353

217

ZXA00

NOMESCO Finland

Right side

3.4

277.6

1384

3474

WX892

NOMESCO Finland

Monitored bed care

5.6

275.8

646

893

OAB50, ,

SPAT

9.4

274.1

405

323

A02BC01

ATC

omeprazole; systemic

3.2

273.8

1554

4225

R50.9

ICD-10 Finland

Fever, unspecified

3.9

272.3

1028

2130

R03BA08

ATC

ciclesonide; inhalant

5.4

269.7

652

929

M54.4

ICD-10 Finland

Lumbago with sciatica

5.1

268.5

695

1056

XG466

NOMESCO Finland

Sleep oxymetry

19.2

268.2

270

103

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.7

268.1

2862

10955

J01AA02

ATC

doxycycline; systemic

3.1

267.3

4381

20903

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.3

266.4

661

965

C10AA05

ATC

atorvastatin; oral

2.7

264.0

2289

7861

M01AX05

ATC

glucosamine; oral

4.4

262.1

833

1509

A10AE05

ATC

insulin detemir; parenteral

121.7

262.1

185

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.8

257.2

997

2100

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

18.0

256.4

265

108

SPAT1263

SPAT

Sampling

2.8

255.7

2026

6614

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

8.0

255.6

423

394

C01DA14

ATC

isosorbide mononitrate; oral

3.8

255.5

1016

2179

J01FA06

ATC

roxithromycin; oral

2.7

254.9

2241

7721

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.0

254.8

1550

4368

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

12.2

254.4

318

193

M10.9

ICD-10 Finland

Gout, unspecified

8.4

254.2

408

365

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

254.1

1337

3452

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

522.3

251.0

284

L01EX09

ATC

nintedanib; oral

+∞

250.0

274

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

92.4

247.8

179

B01AB05

ATC

enoxaparin; parenteral

2.9

246.5

1620

4760

L03

ICPC

Low back symptom/complaint

3.3

246.2

1275

3253

B01AA03

ATC

warfarin; systemic

3.4

244.7

1173

2849

I50.0

ICD-10 Finland

Congestive heart failure

5.5

243.6

572

790

R05

ICPC

Cough

3.1

240.9

1424

3930

ZXE00

NOMESCO Finland

One hour or less

2.7

240.9

2136

7347

S18

ICPC

Laceration/cut

2.6

240.4

2375

8619

Z3231

NOMESCO Finland

Registered nurse

2.9

237.5

1543

4492

J01DB01

ATC

cefalexin; oral

2.8

237.0

4299

20898

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.7

236.3

2044

6929

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.2

234.7

786

1478

A02BC03

ATC

lansoprazole; oral

2.9

234.0

1532

4474

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

11.0

232.8

308

206

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

18.7

232.3

236

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

9.5

231.5

338

264

WX722

NOMESCO Finland

PEEP

12.8

231.2

280

160

H02AB07

ATC

prednisone; oral

3.7

228.6

903

1918

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

3.0

228.5

1418

4011

ACC51

NOMESCO Finland

Release of median nerve

320.4

228.5

263

ZXE10

NOMESCO Finland

More than one and less than three hours

2.7

228.4

1890

6243

L17

ICPC

Foot/toe symptom/complaint

2.9

226.4

1429

4079

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

114.5

224.1

159

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.8

222.9

865

1812

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

28.9

218.5

192

R07.4

ICD-10 Finland

Chest pain, unspecified

2.9

218.2

1434

4177

J01FF01

ATC

clindamycin; systemic

2.9

216.0

1431

4184

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

302.5

215.8

249

L04AA13

ATC

[U] leflunomide

358.8

214.6

246

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

213.1

3168

13685

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

19.2

212.9

214

M01AH01

ATC

celecoxib; oral

3.9

212.4

782

1574

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

15.7

211.3

231

107

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

32.5

211.1

180

M01AH05

ATC

etoricoxib; oral

2.4

209.9

2794

11461

127

Kela drug reimbursment

Transplant complication

20.8

209.3

204

J45.0

ICD-10 Finland

Predominantly allergic asthma

5.0

209.2

545

827

NE1AA

NOMESCO Finland

Pelvis X-ray examination

7.8

206.7

347

328

L04AD01

ATC

ciclosporin; systemic

19.1

206.6

208

N02AA05

ATC

oxycodone; systemic

3.2

205.4

1085

2775

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

563.6

205.2

232

N06AA09

ATC

amitriptyline; systemic

6.1

204.9

429

525

ZXA05

NOMESCO Finland

Left side

3.0

204.7

1238

3428

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

9.6

203.9

293

223

UJF32

NOMESCO Finland

Coloscopy

2.8

203.6

1434

4317

C09AA05

ATC

ramipril; oral

2.8

202.3

1421

4270

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

53.4

201.9

156

GX1K5

NOMESCO Finland

Diffusion capacity

31.8

200.7

172

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.9

200.1

1257

3551

R4120

NOMESCO Finland

Occupational therapy

8.9

200.1

303

249

R04.2

ICD-10 Finland

Haemoptysis

7.2

199.8

358

367

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

+∞

199.4

219

J01MA02

ATC

ciprofloxacin; systemic

2.4

198.8

2115

7789

XF400

NOMESCO Finland

ECG with 12 standard connections

3.3

198.1

941

2249

N06AX11

ATC

mirtazapine; oral

2.6

198.0

1572

5027

A10BH05

ATC

linagliptin; oral

808.1

197.9

222

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

8.6

197.4

308

264

WX723

NOMESCO Finland

CPAP therapy

329.8

197.3

227

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

18.6

196.6

200

N06AX21

ATC

duloxetine; oral

5.5

196.6

457

622

C08CA01

ATC

amlodipine; oral

2.5

196.3

1996

7190

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

21.1

196.1

190

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

792.9

194.2

218

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.0

192.0

1141

3117

J01CA04

ATC

amoxicillin; systemic

2.6

191.6

4283

21760

G44.2

ICD-10 Finland

Tension-type headache

5.0

191.0

496

749

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.2

190.4

476

694

R60.0

ICD-10 Finland

Localized oedema

4.1

190.4

640

1199

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

6.6

190.3

370

417

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.5

190.2

1805

6278

J47

ICD-10 Finland

Bronchiectasis

11.6

190.0

243

153

M20.1

ICD-10 Finland

Hallux valgus (acquired)

8.9

189.9

288

237

M01AH02

ATC

rofecoxib; oral

4.3

189.6

600

1072

H02AB04

ATC

methylprednisolone; systemic

3.4

185.1

820

1868

N02BF02

ATC

pregabalin; oral

7.8

184.9

309

290

R53

ICD-10 Finland

Malaise and fatigue

2.9

184.7

1102

3012

N05CF01

ATC

zopiclone; oral

2.5

184.1

1709

5868

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.3

183.4

892

2157

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.0

183.1

629

1197

R03DC03

ATC

montelukast; oral

3.3

182.3

877

2106

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

20.9

182.1

177

L15

ICPC

Knee symptom/complaint

3.0

181.6

1026

2715

WX780

NOMESCO Finland

Remote monitoring CPAP

1406.1

180.6

201

A06AC01

ATC

ispaghula (psylla seeds); oral

2.7

180.6

1299

3925

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

5.1

180.5

454

665

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

179.7

2238

8751

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.1

179.4

453

666

X59

ICD-10 Finland

Exposure to unspecified factor

3.2

178.3

890

2185

R42

ICD-10 Finland

Dizziness and giddiness

2.9

177.8

1048

2839

M01AC06

ATC

meloxicam; systemic, rectal

2.5

177.6

1588

5342

SPAT1325

SPAT

Vaccination

2.5

177.2

1698

5900

R03BA02

ATC

budesonide; inhalant

3.0

176.5

1019

2727

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

47.5

176.4

139

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.7

176.0

395

518

R51.80

ICD-10 Finland

Headache

4.2

174.7

562

1015

SPAT1229

SPAT

Assessment of need for aid

6.5

174.1

341

387

AN1

Coronary angiography

3.8

173.6

650

1316

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.0

172.3

598

1145

L13

ICPC

Hip symptom/complaint

3.3

172.0

792

1846

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

16.5

171.5

183

SPAT1254

SPAT

Administration of medicine

3.6

170.8

683

1448

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.8

170.7

634

1276

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

170.5

1774

6381

WX002

NOMESCO Finland

Sedation and analgesia

2.9

170.1

993

2670

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.3

170.0

528

927

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

20.6

169.9

166

M05BA07

ATC

risedronic acid; oral

11.0

169.1

222

146

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

49.8

168.9

132

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

181.4

168.5

200

M81.9

ICD-10 Finland

Osteoporosis, unspecified

7.9

167.1

277

257

SPAT1310

SPAT

Counselling related to known health issue

2.5

166.7

1429

4691

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.6

166.4

471

765

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

166.3

1627

5681

GX1D5

NOMESCO Finland

Flow volume spirometry

56.8

165.9

127

R81

ICPC

Pneumonia

6.0

165.6

348

426

B01AF02

ATC

apixaban; oral

3.4

165.4

742

1698

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

4.5

165.2

476

785

M47.9

ICD-10 Finland

Spondylosis, unspecified

35.3

165.2

138

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

201.5

164.5

194

R03AK07

ATC

formoterol and budesonide; inhalant

2.7

163.9

1145

3390

R99

ICPC

Respiratory disease other

14.2

163.6

187

M70.6

ICD-10 Finland

Trochanteric bursitis

4.3

163.3

502

873

M01AX17

ATC

nimesulide; oral

2.8

163.2

1098

3186

M79.0

ICD-10 Finland

Rheumatism, unspecified

67.1

163.0

122

A46

ICD-10 Finland

Erysipelas

3.3

163.0

777

1848

ZX120

NOMESCO Finland

Intravenous

3.6

162.6

666

1434

R03BA05

ATC

fluticasone; inhalant

2.9

161.5

985

2709

A10BB01

ATC

glibenclamide; oral

55.4

161.4

124

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.7

161.1

1121

3309

S97

ICPC

Chronic ulcer skin

6.0

161.1

340

418

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.8

160.7

589

1172

ZXA10

NOMESCO Finland

Bilateral

2.9

160.5

994

2756

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.5

160.4

688

1527

E0000UV, ,

ATC

2.2

160.2

2099

8292

ZXD10

NOMESCO Finland

Scheduled procedure

2.3

159.7

1929

7365

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

159.1

175

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.1

158.9

828

2078

M02AA07

ATC

piroxicam; topical

2.3

158.0

1684

6087

D07AC01

ATC

betamethasone; topical

2.3

157.9

1896

7214

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

157.8

1359

4457

M01AB05

ATC

diclofenac; systemic, rectal

2.1

157.6

3127

14529

A04

ICPC

Weakness/tiredness general

3.3

157.2

711

1633

TPH07

NOMESCO Finland

Cathetrisation of artery

3.3

156.9

738

1738

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

5.5

155.6

359

483

R5110, ,

SPAT

5.1

155.0

389

567

M01AE02

ATC

naproxen; oral, rectal

2.1

155.0

2520

10817

M47.82

ICD-10 Finland

Other spondylosis, cervical region

17.5

155.0

161

J01DA01

ATC

[U] cefalexin

2.1

154.8

3074

14250

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

24.8

154.8

142

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.0

154.7

858

2232

L90

ICPC

Osteoarthrosis of knee

7.8

154.6

257

239

SPAT1301

SPAT

No procedures

2.4

153.5

1413

4773

M03BX02

ATC

tizanidine; oral

2.1

153.0

2754

12276

SPAT1153

SPAT

Removal of sutures

2.4

152.7

1414

4788

H25.1

ICD-10 Finland

Senile nuclear cataract

2.3

152.0

1557

5515

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.8

151.6

974

2749

B01AF01

ATC

rivaroxaban; oral

3.8

151.5

547

1075

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

8.6

150.4

232

195

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1240.7

149.6

167

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

149.1

3494

17152

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

20.8

149.1

145

Z2221

NOMESCO Finland

Medical doctor

2.4

148.9

1460

5066

M43.1

ICD-10 Finland

Spondylolisthesis

25.5

148.3

135

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

148.1

2193

9034

NH3EA

NOMESCO Finland

Feet X-ray examination with load

210.3

147.9

174

SPAT1249

SPAT

Treatment-related counselling outside office

2.3

146.8

1717

6424

A06AD11

ATC

lactulose; oral

3.0

146.3

800

2060

L01XE31

ATC

[U] nintedanib

+∞

146.3

161

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

146.3

161

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

145.7

754

1879

C03DA01

ATC

spironolactone; oral

3.3

145.5

667

1542

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.3

145.1

439

752

A01

ICPC

Pain general/multiple sites

4.4

144.8

436

744

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

144.7

570

1191

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.3

144.3

676

1584

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

21.2

143.9

139

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.5

142.4

603

1323

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

9.8

142.0

200

147

T89

ICPC

Diabetes insulin dependent

42.8

142.0

114

N04BC05

ATC

pramipexole; oral

6.0

141.9

296

359

R03BA01

ATC

beclometasone; inhalant

3.0

141.4

796

2082

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

13.4

141.3

166

C10AX09

ATC

ezetimibe; oral

2.9

140.8

829

2224

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.1

140.8

351

508

SPAT1216

SPAT

Assessment of functional ability

3.3

140.7

635

1452

207

Kela drug reimbursment

Chronic arrhythmias

2.8

140.2

851

2321

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.0

139.9

777

2016

ZXD05

NOMESCO Finland

Urgent procedure

2.3

139.2

1469

5242

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

288.7

139.0

161

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

+∞

139.0

153

R06AE07

ATC

cetirizine; oral

2.1

138.4

2096

8656

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

27.5

138.2

123

J01FA10

ATC

azithromycin; systemic

2.0

138.0

2725

12416

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

6.1

137.6

283

338

A10AB01

ATC

insulin (human); parenteral

66.7

137.5

103

L04AB04

ATC

adalimumab; parenteral

18.1

137.4

141

JN4AD

NOMESCO Finland

Body CT examination

2.9

137.4

822

2223

WZC30

NOMESCO Finland

Teaching

2.6

136.8

1001

3010

WZC00

NOMESCO Finland

Treatment plan or consultation

2.1

136.7

1889

7521

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

14.2

136.6

156

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.2

135.7

240

241

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

14.6

134.3

151

L08

ICPC

Shoulder symptom/complaint

2.6

133.9

999

3031

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.3

133.8

1299

4460

M35.3

ICD-10 Finland

Polymyalgia rheumatica

9.0

133.6

200

161

L04AA01

ATC

[U] ciclosporin

22.2

133.5

127

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

133.5

147

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.1

133.0

2038

8425

WW200

NOMESCO Finland

Immunization

6.6

132.8

255

282

D64.9

ICD-10 Finland

Anaemia, unspecified

3.2

132.3

632

1496

XF402

NOMESCO Finland

ECG with work load test

3.4

132.0

565

1246

A02BA02

ATC

ranitidine; systemic

2.6

132.0

986

2991

SPAT1260

SPAT

Consultation of another employee

2.8

131.9

810

2219

XF600

NOMESCO Finland

Bloodpressure measurement

4.7

131.8

362

571

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

534.8

131.4

149

205

Kela drug reimbursment

Chronic hypertension

2.4

131.0

1241

4209

L04AD02

ATC

tacrolimus; systemic

22.5

130.1

123

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

51.4

129.9

101

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

129.8

143

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.0

129.2

430

793

M09AX01

ATC

hyaluronic acid; parenteral

9.9

129.1

181

132

E66.01

ICD-10 Finland

Obesity due to excess calories

5.6

129.0

291

382

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

28.8

128.6

113

A07AA02

ATC

nystatin; oral

4.3

128.4

390

669

Z94.2

ICD-10 Finland

Lung transplant status

266.4

128.2

149

A10BJ06

ATC

semaglutide; parenteral

+∞

128.0

141

R01AD09

ATC

mometasone; nasal

2.1

127.6

2020

8423

A10BD07

ATC

metformin and sitagliptin; systemic

1030.6

126.8

142

R28

ICPC

Limited function/disability (R)

12.1

124.5

154

J46

ICD-10 Finland

Status asthmaticus

8.7

123.5

189

157

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.5

122.6

1023

3264

ZX108

NOMESCO Finland

Inhalation

19.4

122.3

122

M79.1

ICD-10 Finland

Myalgia

3.3

121.6

540

1218

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

16.8

120.3

127

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.5

120.0

205

197

J43.9

ICD-10 Finland

Emphysema, unspecified

6.5

119.4

232

260

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

+∞

118.9

131

GDG10

NOMESCO Finland

Bilateral transplantation of lung

326.4

118.9

137

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

10.4

118.4

160

110

XX9XE

NOMESCO Finland

Other ultrasound examination

42.3

118.0

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

948.5

117.7

132

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.3

117.4

356

609

J20

ICD-10 Finland

Acute bronchitis

3.3

116.7

533

1223

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

46.7

116.4

M03BC01

ATC

orphenadrine (citrate); systemic

2.6

116.4

836

2476

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.6

116.1

455

943

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.9

115.6

296

438

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.8

115.2

306

468

C07AB02

ATC

metoprolol; systemic

2.4

115.1

1010

3290

M01AB55

ATC

diclofenac, combinations; oral

5.0

115.0

290

423

C08CA02

ATC

felodipine; oral

3.3

114.9

506

1134

N03AE01

ATC

clonazepam; systemic

6.2

114.4

231

270

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.8

114.3

712

1957

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

194.1

114.2

135

C10AA03

ATC

pravastatin; oral

4.0

113.9

386

720

TDM10

NOMESCO Finland

Puncture of maxillary antrum

6.0

113.7

236

284

WX721

NOMESCO Finland

Oxygen concentrator therapy

56.2

113.4

A03

ICPC

Fever

2.6

113.4

804

2364

SPAT1255

SPAT

Intravenous administration of medicine

4.1

113.1

361

643

J01FA09

ATC

clarithromycin; systemic

2.1

112.9

1465

5619

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

32.5

112.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.0

112.5

183

165

Z50.1

ICD-10 Finland

Other physical therapy

6.4

112.5

222

253

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.8

112.3

240

298

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.6

112.1

308

485

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.5

111.7

316

510

XG474

NOMESCO Finland

Exhalation nntrogen oxide

7.5

111.6

191

184

Z2446

NOMESCO Finland

Social worker

4.1

109.9

359

651

E66.8

ICD-10 Finland

Other obesity

7.9

109.9

181

166

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

15.7

109.6

119

I20.99

ICD-10 Finland

Angina pectoris, unspecified

4.0

109.3

364

670

E66.00

ICD-10 Finland

Metabolic syndrome

7.0

109.0

198

205

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.3

109.0

488

1104

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

50.3

108.9

L89

ICPC

Osteoarthrosis of hip

12.4

108.7

133

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

15.4

108.7

119

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.8

108.3

385

744

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

22.7

108.2

102

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.2

107.5

332

576

C09CA01

ATC

losartan; oral

2.2

107.3

1252

4593

A10AE06

ATC

insulin degludec; parenteral

+∞

107.0

118

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.6

106.7

783

2337

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

5.0

106.6

266

384

XW000

NOMESCO Finland

Bone marrow biopsy

4.6

106.6

299

479

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

26.3

106.5

250, ,

Kela drug reimbursment

26.3

106.5

R06.2

ICD-10 Finland

Wheezing

5.0

106.3

267

388

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.3

106.1

484

1108

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

10.9

105.9

139

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.5

105.6

436

935

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

105.2

116

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.7

105.2

391

780

W19

ICD-10 Finland

Unspecified fall

3.4

105.1

436

938

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

221.4

104.8

123

L04AB01

ATC

etanercept; parenteral

221.4

104.8

123

XF404

NOMESCO Finland

Ambulatory ECG

3.4

104.2

432

929

N05BA04

ATC

oxazepam; oral

2.2

104.1

1134

4040

H02AB09

ATC

hydrocortisone; systemic

8.3

103.9

164

142

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

16.0

103.8

112

G56.2

ICD-10 Finland

Lesion of ulnar nerve

17.7

103.7

107

UJF30

NOMESCO Finland

Ileoscopy through colon

3.0

103.6

557

1407

R4110, ,

SPAT

3.0

103.0

546

1368

XCK10

NOMESCO Finland

Photography of fundus of eye

3.7

102.7

382

762

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

102.5

985

3327

A01AB09

ATC

miconazole; local oral

3.3

102.2

464

1058

R07.3

ICD-10 Finland

Other chest pain

3.2

102.0

481

1123

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

101.6

112

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

10.4

101.5

137

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.9

101.4

259

382

M01CB01

ATC

sodium aurothiomalate; parenteral

213.8

101.2

119

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

101.1

1410

5523

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.5

101.0

804

2492

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.0

100.9

1624

6698

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.3

100.8

1007

3455

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

33.5

100.5

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

11.6

100.4

127

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

211.9

100.3

118

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

211.9

100.3

118

SPAT1097

SPAT

Recording of ECG

2.7

100.2

667

1892

P20

ICPC

Memory disturbance

3.0

100.1

534

1342

B01AX06

ATC

[U] rivaroxaban

50.3

99.9

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.8

99.7

355

686

Angiography of the heart and coronary arteries

3.8

99.2

348

665

R05FB02

ATC

cough suppressants and expectorants; systemic

1.9

99.1

1787

7655

M54.1

ICD-10 Finland

Radiculopathy

10.1

99.0

136

212

Kela drug reimbursment

Gout

+∞

98.8

109

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

791.9

98.7

111

SAA03

NOMESCO Finland

Extended examination of mouth

1.9

98.5

1707

7212

M10.0

ICD-10 Finland

Idiopathic gout

7.5

98.5

168

161

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

23.4

98.5

Z3229

NOMESCO Finland

Other healthcare associate professional

3.3

97.7

435

979

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

97.6

474

1126

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

206.3

97.6

115

SPAT1053

SPAT

Memory test

2.8

97.5

592

1599

J45.8

ICD-10 Finland

Mixed asthma

6.2

97.4

196

228

WX725

NOMESCO Finland

Noninvasive ventilation

3.9

97.2

335

632

N18.8

ICD-10 Finland

Other chronic renal failure

8.6

97.1

149

124

L86

ICPC

Back syndrome with radiating pain

5.3

97.0

228

311

N06AX16

ATC

venlafaxine; oral

3.0

96.4

507

1263

R52.9

ICD-10 Finland

Pain, unspecified

3.4

96.4

412

903

ZXE20

NOMESCO Finland

More than three and less than five hours

2.6

96.1

691

2036

D86.0

ICD-10 Finland

Sarcoidosis of lung

9.9

96.0

134

C08CA05

ATC

nifedipine; systemic

3.8

95.9

344

668

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.8

95.9

566

1505

R06.5

ICD-10 Finland

Mouth breathing

3.8

95.7

335

639

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.6

95.2

681

2001

M54.3

ICD-10 Finland

Sciatica

6.0

95.1

196

234

NBG10

NOMESCO Finland

Acromioplastia

29.5

95.1

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

136.9

95.1

115

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

14.3

95.0

108

J45

ICD-10 Finland

Asthma

3.0

94.9

494

1223

GX2C5

NOMESCO Finland

Short-lasting oximetry

24.7

94.8

M20.2

ICD-10 Finland

Hallux rigidus

31.9

94.7

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

755.5

94.1

106

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.7

94.0

350

698

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

93.9

586

1605

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.3

93.6

281

476

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.4

93.1

400

879

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.2

93.0

289

503

R29

ICPC

Respiratory symptom/complaint other

3.6

92.9

353

714

H03AA01

ATC

levothyroxine sodium; systemic

2.2

92.5

979

3431

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

14.0

92.4

106

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.7

92.4

581

1597

N05AH04

ATC

quetiapine; oral

2.7

92.2

601

1683

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.3

92.1

398

878

XX2RW, ,

NOMESCO Finland

7.7

92.0

153

142

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.5

91.7

361

748

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

16.2

91.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

91.0

726

2246

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

6.3

91.0

179

203

R03AC13

ATC

formoterol; inhalant

4.0

90.7

300

548

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

90.7

318

607

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

90.6

100

R03AC03

ATC

terbutaline; inhalant

2.6

90.4

644

1886

M05BX04

ATC

denosumab; parenteral

3.5

90.3

363

763

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.3

89.7

268

452

R01AD08

ATC

fluticasone; nasal

2.0

89.6

1264

4942

G04CA02

ATC

tamsulosin; oral

2.0

89.6

1316

5221

SPAT1211

SPAT

Application of soft bandage

3.4

89.4

370

793

L12

ICPC

Hand/finger symptom/complaint

2.5

89.1

675

2037

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

88.8

UKC02

NOMESCO Finland

Cystoscopy

2.3

88.8

826

2737

NA1AD

NOMESCO Finland

Cervical spine CT examination

6.3

88.8

175

199

J02AC01

ATC

fluconazole; systemic

1.9

88.7

1608

6854

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

11.8

88.6

111

R96

ICPC

Asthma

3.1

88.5

441

1063

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.3

88.3

824

2734

WX872

NOMESCO Finland

Intensive care

3.6

88.1

331

664

GX2D5

NOMESCO Finland

Sleep oximetry

45.1

88.0

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

87.9

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

704.7

87.8

NG2AA

NOMESCO Finland

Patella X-ray examination

23.3

87.7

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.5

87.7

354

746

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.9

87.7

474

1198

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

11.2

87.5

113

X58

ICD-10 Finland

Exposure to other specified factors

2.6

87.3

592

1690

R55

ICD-10 Finland

Syncope and collapse

2.8

87.1

517

1376

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.7

87.1

562

1564

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

9.5

86.8

124

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

22.4

86.6

P06

ICPC

Sleep disturbance

3.0

86.6

444

1088

SPAT1312

SPAT

General health counselling

2.0

86.5

1314

5266

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

86.5

411

962

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

5.1

86.3

209

293

Z51.5

ICD-10 Finland

Palliative care

2.6

86.0

612

1790

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.1

85.8

413

974

S22.3

ICD-10 Finland

Fracture of rib

3.5

85.8

349

739

Z71.8

ICD-10 Finland

Other specified counselling

1.9

85.8

1447

6010

NG1DA

NOMESCO Finland

X-ray of knees

95.4

85.7

107

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.6

85.4

592

1708

L40.5

ICD-10 Finland

Arthropathic psoriasis

34.0

85.4

I50.1

ICD-10 Finland

Left ventricular failure

4.0

85.1

284

522

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

84.8

394

909

WX111

NOMESCO Finland

Local infiltration anesthesia

94.5

84.8

106

C08CA13

ATC

lercanidipine; oral

2.5

84.8

616

1819

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.0

84.4

439

1084

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.5

84.4

339

712

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

84.3

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

5.4

84.2

192

254

M79.7

ICD-10 Finland

Fibromyalgia

16.6

84.1

N06AB04

ATC

citalopram; systemic

2.2

84.0

828

2808

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

16.9

83.7

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.3

83.6

358

784

XA402

NOMESCO Finland

ENMG

20.1

83.4

L01

ICPC

Neck symptom/complaint

2.5

83.2

616

1835

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

6.2

83.1

167

194

J01FA15

ATC

telithromycin; oral

2.8

83.0

488

1291

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.0

82.8

1159

4504

L29

ICPC

Musculoskeletal sympt/complt other

3.3

82.7

354

775

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

19.0

82.7

H03BB01

ATC

carbimazole; oral

14.9

82.6

M10

ICD-10 Finland

Gout

4.6

82.5

227

357

D07AC13

ATC

mometasone; topical

1.9

82.5

1378

5693

M50.3

ICD-10 Finland

Other cervical disc degeneration

21.6

82.4

R52.2

ICD-10 Finland

Other chronic pain

7.8

82.4

136

125

J05AB01

ATC

aciclovir; systemic

2.1

81.9

1032

3856

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

81.5

552

1573

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.8

81.5

173

213

R13

ICD-10 Finland

Dysphagia

3.5

81.4

320

662

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

81.3

2461

12174

I95.1

ICD-10 Finland

Orthostatic hypotension

5.8

81.3

174

216

P01AB01

ATC

metronidazole; oral, rectal

1.8

81.2

1750

7838

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

223.9

81.1

R11

ICD-10 Finland

Nausea and vomiting

3.2

81.1

377

870

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.5

80.9

327

689

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

80.6

I20.09

ICD-10 Finland

Unstable angina

3.7

80.5

293

574

R04.0

ICD-10 Finland

Epistaxis

3.1

80.4

399

958

N03AF02

ATC

oxcarbazepine; oral

20.0

80.3

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.7

80.2

289

562

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.7

80.2

297

589

L16

ICPC

Ankle symptom/complaint

2.9

80.2

452

1168

I25.2

ICD-10 Finland

Old myocardial infarction

3.1

79.9

388

919

WZA90

NOMESCO Finland

Other medical or dental certificate

2.1

79.9

916

3298

R01AD12

ATC

fluticasone furoate; nasal

1.9

79.4

1279

5211

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.3

79.3

704

2279

J96.0

ICD-10 Finland

Acute respiratory failure

8.3

79.3

124

106

G51.0

ICD-10 Finland

Bell palsy

21.6

79.3

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

632.3

78.7

WZA10

NOMESCO Finland

Extensive medical or dental certificate

10.7

78.6

104

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

20.2

78.5

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

219.5

78.4

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.5

78.3

310

644

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.4

78.2

326

701

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

4.9

78.1

201

298

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

33.4

77.9

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

9.5

77.8

111

R4130

NOMESCO Finland

Speech therapy

6.9

77.6

141

146

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

10.0

77.5

107

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

112.7

77.3

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

18.1

77.2

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

315.3

77.1

L95

ICPC

Osteoporosis

4.5

77.1

217

348

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

6.4

76.9

149

166

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.4

76.6

320

689

K02.1

ICD-10 Finland

Caries of dentine

1.7

76.5

2581

13084

WX882

NOMESCO Finland

High dependency care

5.5

76.2

170

220

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

76.1

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

8.7

75.9

115

M02AA10

ATC

ketoprofen; topical

2.4

75.9

644

2041

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

3.3

75.8

335

748

E000001, ,

ATC

2.1

75.2

872

3147

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

5.9

75.0

158

193

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

24.4

74.9

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

74.9

2901

15230

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.7

74.7

139

148

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.7

74.4

161

202

R03AK11

ATC

formoterol and fluticasone; inhalant

5.9

74.2

156

190

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.2

74.2

340

777

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.5

74.1

141

154

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

73.7

1034

4003

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

73.7

1124

4481

R04

ICPC

Breathing problem other

5.0

73.7

182

260

XA800

NOMESCO Finland

Neuropsychological investigation

7.6

73.6

124

117

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

300.8

73.5

D11

ICPC

Diarrhoea

2.7

73.4

465

1278

M17.5

ICD-10 Finland

Other secondary gonarthrosis

33.7

73.4

S29

ICPC

Skin symptom/complaint other

2.0

72.9

922

3436

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

106.7

72.9

G04BD12

ATC

mirabegron; oral

2.6

72.9

491

1393

A10AA02, ,

ATC

92.5

72.7

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

72.7

3203

17343

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

19.6

72.6

N03AF01

ATC

carbamazepine; oral, rectal

5.2

72.4

171

234

B02.9

ICD-10 Finland

Zoster without complication

2.9

72.1

400

1023

J80

ICD-10 Finland

Adult respiratory distress syndrome

20.7

71.9

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

91.4

71.8

WX204

NOMESCO Finland

Axillary plexus blockaced

6.0

71.8

149

179

I50

ICD-10 Finland

Heart failure

5.4

71.4

163

216

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

5.5

71.3

161

211

J05AB11

ATC

valaciclovir; oral

2.2

71.3

734

2524

A10AB04

ATC

insulin lispro; parenteral

90.4

71.0

GD2SN

NOMESCO Finland

Lung ventilation SPECT

16.6

70.8

SFA10

NOMESCO Finland

One-surface restoration

1.7

70.7

2387

12022

G40.9

ICD-10 Finland

Epilepsy, unspecified

567.3

70.6

A08

ICPC

Swelling

3.9

70.5

239

444

M54.6

ICD-10 Finland

Pain in thoracic spine

3.9

70.5

238

441

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.3

70.2

303

666

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

40.3

70.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

69.9

1932

9213

C09AA02

ATC

enalapril; systemic

2.1

69.8

840

3069

A10BG03

ATC

pioglitazone; oral

+∞

69.7

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

13.2

69.7

XJC10

NOMESCO Finland

Oesophageal pH monitoring

22.2

69.6

C03AA03

ATC

hydrochlorothiazide; oral

2.9

69.6

366

908

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.8

69.4

114

104

B01AB04

ATC

dalteparin; parenteral

3.6

69.3

260

520

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

5.6

69.3

153

196

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.1

69.0

219

387

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.9

69.0

234

435

A41.9

ICD-10 Finland

Sepsis, unspecified

4.2

69.0

209

356

N02AA01

ATC

morphine; systemic, rectal

4.4

68.9

201

332

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.7

68.9

149

187

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.1

68.8

219

388

N17

ICPC

Vertigo/dizziness

2.5

68.7

506

1498

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

36.6

68.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

68.2

478

1382

K77

ICPC

Heart failure

7.4

68.1

117

113

M01AB01

ATC

indometacin; systemic, rectal

3.1

68.1

330

780

WX402

NOMESCO Finland

General anaesthesia

1.9

68.1

1076

4329

R60.9

ICD-10 Finland

Oedema, unspecified

3.7

68.0

245

476

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.9

68.0

231

430

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

545.7

67.9

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.5

67.7

265

546

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.8

67.6

398

1051

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.2

67.5

312

716

A29

ICPC

General symptom/complaint other

2.3

67.5

575

1821

TK800

NOMESCO Finland

Hemodialysis

7.1

67.5

120

121

M54.2

ICD-10 Finland

Cervicalgia

3.8

67.4

239

459

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

275.5

67.3

J31.0

ICD-10 Finland

Chronic rhinitis

2.9

67.2

356

886

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

7.8

67.2

111

102

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.3

67.1

200

336

N05CD07

ATC

temazepam; oral

2.4

67.1

562

1766

SPAT1054

SPAT

Examination of peripheral nervous system

38.9

67.1

B01AB10

ATC

tinzaparin; parenteral

2.5

67.1

509

1528

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

67.1

407

1092

-1, ,

NOMESCO Finland

1.8

67.0

1349

5859

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

66.1

1777

8380

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

+∞

66.1

N30.0

ICD-10 Finland

Acute cystitis

2.2

66.0

642

2152

M19.9

ICD-10 Finland

Arthrosis, unspecified

5.3

66.0

155

211

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

6.1

65.9

133

155

Z01.2

ICD-10 Finland

Dental examination

1.7

65.8

1965

9530

C10AA04

ATC

fluvastatin; oral

2.9

65.6

361

918

NHQ40

NOMESCO Finland

Amputation of toe

14.0

65.5

NF1DA

NOMESCO Finland

X-ray of hips

113.6

65.2

A11

ICPC

Chest pain NOS

2.8

65.2

385

1018

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

+∞

65.2

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

65.0

353

891

K07

ICPC

Swollen ankles/oedema

4.1

64.9

206

364

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.4

64.9

262

551

N02AJ13

ATC

tramadol and paracetamol; systemic

13.0

64.9

K90

ICPC

Stroke/cerebrovascular accident

83.2

64.8

9211

FHL

Exploration or removal of diskusprolapse

264.7

64.6

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

64.5

518

1596

K78

ICPC

Atrial fibrillation/flutter

2.9

64.5

355

903

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

6.3

64.4

126

142

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

64.3

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

+∞

64.3

SPAT1058

SPAT

PEF monitoring instruction

3.0

64.2

329

803

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.8

64.1

225

429

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.5

64.1

459

1340

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

26.9

63.6

N19

ICD-10 Finland

Unspecified kidney failure

4.3

63.6

190

320

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.2

63.1

286

648

N05BA01

ATC

diazepam; systemic, rectal

2.4

63.1

526

1648

R20.2

ICD-10 Finland

Paraesthesia of skin

3.6

63.1

236

471

N06DX01

ATC

memantine; oral

4.2

62.9

191

326

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.6

62.8

406

1126

M54

ICD-10 Finland

Dorsalgia

2.6

62.8

431

1232

SPAT1202

SPAT

Intra-articular injection

6.9

62.7

114

118

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

18.1

62.6

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.3

62.6

265

575

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

62.5

D07AD01

ATC

clobetasol; topical

2.0

62.4

771

2836

SPAT1377

SPAT

Polysomnography

6.6

62.4

118

128

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

11.1

61.9

R03AC12

ATC

salmeterol; inhalant

3.2

61.8

281

638

L04AA24

ATC

abatacept; parenteral

+∞

61.6

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

5.0

61.6

152

217

WZA00

NOMESCO Finland

Concise certificate

3.7

61.5

223

435

J43.8

ICD-10 Finland

Other emphysema

16.1

61.5

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

6.9

61.5

111

114

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.9

61.4

129

157

R74

ICPC

Upper respiratory infection acute

1.8

61.4

1221

5263

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

5.1

61.4

150

212

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

10.1

61.3

XQ800

NOMESCO Finland

Prick test

3.1

61.2

295

694

SPAT1281

SPAT

Other administrative function

3.0

61.1

311

756

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

250.3

61.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.1

60.9

190

331

Z01.9

ICD-10 Finland

Special examination, unspecified

3.3

60.8

265

586

SPAT1252

SPAT

Overall medication plan or its review

3.2

60.7

271

608

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

+∞

60.7

I48.2

ICD-10 Finland

Chronic atrial fibrillation

3.8

60.6

212

403

J92.9

ICD-10 Finland

Pleural plaque without asbestos

7.3

60.4

105

103

XG405

NOMESCO Finland

Education on PEF monitoring

7.0

60.2

108

110

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.1

60.2

122

143

R5599

NOMESCO Finland

Other rehabilitation service

6.8

60.0

110

115

L02

ICPC

Back symptom/complaint

2.7

60.0

359

955

JN4BD

NOMESCO Finland

Extensive body CT

2.1

60.0

638

2214

M65.3

ICD-10 Finland

Trigger finger

5.4

60.0

136

179

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

32.7

59.9

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.2

59.9

616

2109

ZXD20

NOMESCO Finland

Day surgery

2.3

59.9

503

1580

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

11.5

59.8

1220

FHL

Arthroscopy

6.9

59.8

108

111

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

59.7

U02

ICPC

Urinary frequency/urgency

2.2

59.4

588

1981

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.0

59.4

122

145

WX200

NOMESCO Finland

Interscalenous plexus blockade

11.6

59.3

D01

ICPC

Abdominal pain/cramps general

2.4

59.3

461

1398

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

59.2

1067

4456

R1250

NOMESCO Finland

Evaluation of functional capability

8.4

59.2

WX720

NOMESCO Finland

Own respiration

3.4

59.1

247

531

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

59.1

4324

25955

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

12.0

59.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.9

59.0

150

220

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

473.8

58.9

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

473.8

58.9

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

11.7

58.8

G04BD08

ATC

solifenacin; oral

3.1

58.8

273

628

G20

ICD-10 Finland

Parkinson disease

76.0

58.7

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

34.6

58.3

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.8

58.2

203

385

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

58.2

206

395

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

102.1

58.2

ZYC01

NOMESCO Finland

Remote contact by phone

3.1

58.2

273

632

D72.1

ICD-10 Finland

Eosinophilia

17.7

58.2

ZY010

NOMESCO Finland

Hospital outpatient

3.9

57.9

197

367

A10BJ02

ATC

liraglutide; parenteral

75.0

57.9

EBA00

NOMESCO Finland

Extraction of tooth

1.7

57.8

1525

7104

XX4BW, ,

NOMESCO Finland

66.5

57.8

N03AX14

ATC

levetiracetam; systemic

10.8

57.7

D07XC01

ATC

betamethasone; topical

2.2

57.7

571

1923

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

26.2

57.7

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.8

57.5

320

818

TNG10

NOMESCO Finland

Puncture of knee

235.9

57.4

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

235.9

57.4

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3017143) Hepatitis C virus Ab [Presence] in Serum

1045

1944

4.39

321.80

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

289

26.93

321.53

1.3

1.1

65.91

—

u/ml

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2171

6680

3.07

317.60

3.2

2.6

63.15

75.87

u/l

0.72

2036

6169

(3028626) Oxygen [Partial pressure] in Capillary blood

474

386

9.29

316.91

5.6

3.8

7.81

8.27

kpa

4.30

463

374

(3042631) Mycobacterium sp identified in Specimen

601

261

17.92

307.65

2.9

2.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2055

4828

4.11

307.65

5.2

2.3

355.21

340.94

umol/l

6.42

1845

4334

(3018418) pH of Serum or Plasma

2720

6238

4.96

307.65

6.4

3.7

7.40

1.33

2052

4159

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

787

285

22.30

307.65

1.4

1.1

3.86

2.08

u/ml

1.20

(3016502) Oxygen saturation in Arterial blood

1409

1997

6.25

307.65

11.6

8.2

93.90

95.94

16.89

1364

1927

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3826

10967

5.48

307.65

12.6

5.7

1.21

mmol/l

4.30

3360

9299

(3015736) pH of Urine

2703

8947

3.14

307.65

4.5

2.5

6.22

6.18

0.94

1341

4954

(3022096) Basophils/Leukocytes in Blood

4148

10094

8.09

307.65

14.7

5.0

0.66

0.68

1.84

4093

9370

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1484

2708

4.85

307.65

3.1

2.0

21.07

24.20

10.52

1394

2521

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1014

469

18.23

307.65

2.4

1.5

—

(3019069) Monocytes/Leukocytes in Blood

4164

10093

8.21

307.65

14.7

5.1

8.95

9.08

1.81

4108

9395

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1455

527

25.69

307.65

1.8

1.1

11.99

3.42

iu/ml

—

(3021901) Oxygen saturation in Capillary blood

431

271

11.97

307.65

4.7

2.5

89.05

89.32

0.22

420

263

(3012516) Albumin [Mass/volume] in Urine

2064

5007

3.97

307.65

4.0

1.8

56.81

32.37

mg/l

5.25

1401

2493

(3013826) Glucose [Moles/volume] in Serum or Plasma

3922

12720

4.80

307.65

9.9

4.0

6.77

6.25

mmol/l

52.81

3809

11949

(3004588) Protein electrophoresis panel - Serum or Plasma

849

873

7.84

307.65

2.2

2.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

334

123

20.14

307.65

2.1

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

433

260

12.54

307.65

1.7

1.3

0.96

0.83

g/l

0.71

318

193

(3021960) Folate [Moles/volume] in Serum or Plasma

1956

5414

3.34

307.65

1.9

1.5

19.27

20.11

nmol/l

1.52

1718

4443

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

519

246

16.16

307.65

1.4

1.1

58.80

26.01

u/ml

1.25

(44790049) Parainfluenza type 3 nucleic acid detection

520

230

17.33

307.65

2.7

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

779

285

22.04

307.65

1.4

1.1

12.92

4.40

u/ml

2.10

141

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2000

4767

4.00

307.65

2.8

2.0

3.04

2.83

mg/l

2.63

1789

4006

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1920

3816

4.82

307.65

2.6

1.5

1.50

1.73

mg/l

1.13

1611

2970

(44790048) Parainfluenza type 2 nucleic acid detection

520

230

17.33

307.65

2.7

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

642

394

12.74

307.65

13.0

4.0

1365.62

361.44

iu/ml

0.53

152

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

458

300

11.54

307.65

5.7

2.2

657.42

1152.92

u/ml

0.36

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2104

1936

11.54

307.65

1.4

1.1

22.95

1.38

u/ml

9.22

626

738

(3018095) Leukocytes [#/volume] in Urine

2826

8564

3.62

307.65

6.6

3.1

100.31

118.59

e6/l

0.32

2152

5691

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

265

129.71

307.65

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1552

2946

4.71

307.65

3.1

1.9

2.26

2.28

g/l

0.68

1448

2731

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

998

377

22.30

307.65

2.2

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

2351

6448

3.66

307.65

5.1

2.7

0.34

0.59

e6/l

4.00

1831

4382

(3028026) IgM [Mass/volume] in Serum or Plasma

1150

977

10.09

307.65

2.3

2.2

1.13

1.52

g/l

2.42

1085

894

(3000850) Epithelial cells [#/volume] in Urine

1945

4696

3.90

307.65

3.9

2.3

4.78

5.45

e6/l

0.80

1815

4210

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

597

437

10.58

307.65

1.9

2.1

11.49

11.28

mg/l

0.18

562

414

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4686

19514

5.02

307.65

17.2

7.7

79.18

83.16

u/l

5.29

4609

18307

(3006184) Hemoglobin [Mass/volume] in Capillary blood

655

393

13.07

307.65

2.7

1.8

128.35

129.69

g/l

0.34

309

307

(3031040) Bacteria [#/volume] in Urine by Automated count

3926

15359

3.59

307.65

6.8

3.3

695.12

844.56

e6/l

0.11

211

(3021601) Nitrite [Presence] in Urine by Test strip

3339

11557

3.50

307.65

5.6

2.7

0.00

estimate

1.08

971

2237

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

103

23.30

307.65

2.1

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1410

2696

4.55

307.65

3.0

2.1

29.91

30.23

0.96

1383

2626

(3007164) IgA [Mass/volume] in Serum or Plasma

1730

3649

4.34

307.65

2.1

1.4

2.74

2.41

g/l

6.26

1279

2191

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

310

25.17

307.65

2.1

1.5

—

(3021589) Normoblasts [#/volume] in Blood

3318

10919

3.74

307.65

23.7

8.4

0.00

e9/l

0.09

2826

8663

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1018

1787

4.65

307.65

5.4

3.0

5.86

5.78

kpa

1.34

984

1741

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

265

129.71

307.65

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

601

415

11.23

307.65

4.5

2.7

25.30

24.95

mmol/l

0.66

584

403

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

545

279

15.03

307.65

1.2

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2652

7605

3.72

307.65

5.4

2.6

104.52

70.14

ng/l

0.23

2146

4953

(3023520) Reticulocytes [#/volume] in Blood

974

1674

4.71

307.65

3.5

2.7

72.52

65.14

e9/l

5.20

670

1226

(3023420) DNA double strand Ab [Units/volume] in Serum

1083

347

26.80

307.65

2.1

1.3

7.68

2.85

iu/ml

4.30

238

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

962

1252

6.28

307.65

12.9

9.6

24.68

24.35

mmol/l

1.77

933

1222

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3620

9825

5.41

307.65

11.4

5.4

1.20

1.21

mmol/l

4.66

3474

8975

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1652

4182

3.50

307.65

5.4

3.0

450.37

942.61

ng/l

4.45

1450

3346

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

313

25.71

307.65

2.1

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

342

41.04

307.65

1.9

1.1

—

(3013115) Eosinophils [#/volume] in Blood

4450

11212

9.42

307.65

14.8

5.1

0.21

0.19

e9/l

12.16

4115

9394

(3013637) Mi-2 Ab [Presence] in Serum

265

129.71

307.65

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

1199

1553

6.59

307.65

7.3

3.7

0.07

0.09

0.44

454

463

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

854

1211

5.64

307.65

2.0

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

597

209

22.24

307.65

2.4

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2989

9941

3.35

307.65

3.3

2.0

77.66

78.21

nmol/l

0.45

2807

8945

(3024139) IgG subclass 3 [Mass/volume] in Serum

341

134

18.89

307.65

1.5

1.2

0.49

0.45

g/l

0.36

240

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1671

3580

4.22

307.65

7.4

3.9

0.81

0.82

mmol/l

5.16

1586

3405

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1004

461

18.33

307.65

2.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

378

116

24.38

307.65

1.4

1.1

63.78

37.96

u/ml

—

(3001604) Monocytes [#/volume] in Blood

4404

10770

9.49

307.65

14.0

4.8

0.66

0.59

e9/l

39.53

4022

8873

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

583

217

20.86

307.65

1.3

1.1

323.28

166.67

titre

1.02

(3005719) IgG [Mass/volume] in Serum or Plasma

1471

1154

11.72

307.65

4.6

2.7

10.30

10.84

g/l

2.26

1416

1064

(3004616) Nuclear Ab [Presence] in Serum

350

111

23.46

307.65

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

678

256

20.93

307.65

1.9

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2299

2947

8.53

307.65

3.0

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1125

518

18.74

307.65

1.9

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1659

2290

6.77

307.65

10.8

7.7

10.44

13.35

kpa

68.11

1603

2199

(3006504) Eosinophils/Leukocytes in Blood

4160

10072

8.20

307.65

14.5

5.0

2.80

2.86

0.74

4102

9377

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1661

2292

6.77

307.65

10.8

7.7

5.04

5.14

kpa

2.82

1605

2200

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

795

311

20.66

307.65

1.4

1.1

45.45

4.35

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

989

1346

6.02

307.65

2.3

3.2

66.03

65.50

g/l

0.90

945

1242

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2774

8118

3.74

307.65

5.4

2.7

—

3.57

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

341

135

18.75

307.65

1.5

1.2

2.94

3.28

g/l

1.11

242

(3009508) Creatinine [Moles/volume] in Urine

2137

5445

3.81

307.65

4.0

1.8

7.03

8.29

mmol/l

28.45

1805

4555

(44806118) Parainfluenza type 4 nucleic acid detection

520

230

17.33

307.65

2.7

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

520

230

17.33

307.65

2.7

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1158

459

21.96

307.65

1.3

1.1

—

(3023419) Bacteria identified in Sputum by Culture

680

211

25.51

307.65

2.8

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

834

740

9.08

307.65

5.8

3.7

2.28

1.99

mmol/l

0.84

656

536

(3002030) Lymphocytes/Leukocytes in Blood

4173

10429

7.92

307.65

14.7

5.0

24.99

27.85

43.12

4122

9816

(3002032) Base excess in Venous blood by calculation

989

1738

4.62

307.65

5.4

3.0

2.12

1.76

mmol/l

1.62

872

1507

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

885

638

11.33

307.65

2.0

2.3

39.02

42.00

u/l

2.28

820

577

(3024561) Albumin [Mass/volume] in Serum or Plasma

3352

10182

4.21

307.65

7.3

5.0

33.85

35.29

g/l

32.73

3178

9539

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

566

137.50

307.65

1.1

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

1054

1057

8.35

307.65

1.7

1.2

240.65

303.99

u/ml

0.75

987

983

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1282

1546

7.22

307.65

2.2

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

717

300

19.02

307.65

2.0

1.2

0.23

0.24

g/l

1.49

695

278

(42529582) MDA5 Ab [Presence] in Serum by Line blot

265

129.71

307.65

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

952

371

21.40

307.65

1.3

1.1

2.14

0.82

u/ml

1.04

(3027135) IgG subclass 1 [Mass/volume] in Serum

342

136

18.67

307.65

1.5

1.2

7.44

6.88

g/l

0.91

242

(3015377) Calcium [Moles/volume] in Serum or Plasma

2576

8171

3.22

307.65

4.6

4.7

2.34

2.36

mmol/l

5.28

2403

7445

(1616796) Gas panel - Central venous blood

452

319

10.69

307.65

5.8

3.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2950

5901

6.24

307.65

4.4

2.5

1552.11

1207.13

ng/l

3.04

2672

5105

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2456

4512

5.98

307.65

3.8

1.7

153.86

199.84

u/l

2.98

2349

4196

(3018010) Neutrophils/Leukocytes in Blood

4131

10127

7.93

307.65

14.1

4.8

59.98

56.87

41.97

4095

9629

(3037522) Nuclear Ab [Titer] in Serum

2447

1720

16.82

307.65

1.6

1.2

575.97

419.47

titre

2.28

714

304

(3014576) Chloride [Moles/volume] in Serum or Plasma

1387

2954

4.03

307.65

13.4

7.1

103.88

104.68

mmol/l

5.97

1387

2954

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4629

16199

6.57

307.65

10.9

2.5

17.48

11.58

mm/h

91.15

4550

14648

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

731

722

7.99

307.65

2.5

1.8

2.05

2.57

ug/l

0.24

660

656

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4004

12701

5.16

307.65

11.4

8.1

11.09

13.22

umol/l

12.43

3916

12131

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2652

8893

3.05

307.65

2.3

1.7

93.66

95.80

pmol/l

1.28

1475

4523

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

638

226

22.15

307.65

2.6

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

4420

11054

9.31

307.65

14.2

4.8

1.90

1.95

e9/l

0.60

4085

9360

(3003396) Base excess in Arterial blood by calculation

1645

2285

6.70

307.65

10.7

7.6

1.31

0.80

mmol/l

3.94

1407

1907

(3035350) Ketones [Presence] in Urine by Test strip

3362

11712

3.50

307.65

5.6

2.7

5.86

1.28

estimate

0.84

993

2267

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

838

124

55.38

307.65

2.1

1.4

—

(3023368) Bacteria identified in Blood by Culture

2870

5742

6.09

307.65

6.3

3.8

—

(3032080) INR in Blood by Coagulation assay

3510

9876

4.94

307.65

17.5

11.7

1.27

1.25

inr

1.36

3028

8115

(3020682) Albumin/Creatinine [Ratio] in Urine

2117

5112

4.04

307.65

4.8

2.0

10.81

5.22

mg/mmol

4.75

1374

2497

(3020779) Urea [Moles/volume] in Serum or Plasma

1084

1758

5.10

307.65

12.4

5.3

10.30

9.01

mmol/l

5.52

1048

1691

(3002179) Metamyelocytes/Leukocytes in Blood

1233

1549

6.85

307.65

6.9

3.7

0.59

0.77

1.46

514

533

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

514

361

10.86

307.65

1.6

1.4

60.74

0.09

iu/ml

1.06

102

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

791

1065

5.88

307.65

2.1

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1641

3165

4.71

307.65

3.1

2.0

11.71

13.82

umol/l

19.51

1541

2958

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

436

188

17.51

307.65

3.6

3.2

—

(3017732) Neutrophils [#/volume] in Blood

1220

2308

4.44

307.65

4.0

3.1

4.70

4.31

e9/l

1.32

1117

1985

(3013650) Neutrophils [#/volume] in Blood by Automated count

4437

13223

7.32

307.65

18.1

10.1

4.63

4.00

e9/l

44.26

4083

11113

(3026782) Osmolality of Urine

1774

4175

3.88

307.65

4.0

2.5

514.29

549.92

mosm/kgh2o

9.47

1623

3622

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

740

224

26.46

307.65

1.3

1.1

21.08

1.34

u/ml

—

(4062490) Immunoglobulin typing, IgG

332

133

18.50

307.65

1.5

1.2

—

(3025159) Blasts/Leukocytes in Blood

1197

1589

6.42

307.65

7.4

3.8

0.11

0.94

1.76

445

463

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

723

308

18.70

307.65

2.0

1.2

1.20

1.18

g/l

0.44

704

287

(3006315) Basophils [#/volume] in Blood

4406

10801

9.47

307.65

14.0

4.8

0.04

e9/l

8.23

4026

8905

(46235355) HIV 1 and 2 tests - Meaningful Use set

1459

2869

4.45

307.65

1.6

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

912

302

25.02

307.65

2.1

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

2606

7445

3.69

307.65

5.3

2.8

38.69

112.91

e6/l

2.99

2092

5318

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1124

1377

6.89

307.65

2.3

3.3

337.04

407.13

nmol/l

13.30

1073

1309

(3019977) pH of Arterial blood

1646

2293

6.68

307.65

10.8

7.6

7.42

1.35

1026

1092

(3000494) Fungus identified in Specimen by Culture

1555

2574

5.46

307.65

2.4

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

288

29.45

307.65

1.3

1.1

—

(3026008) Bacteria identified in Urine by Culture

2042

5896

3.23

307.65

3.9

2.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1208

1929

5.31

307.65

13.2

8.2

123.09

120.38

g/l

3.17

1184

1877

(3009343) pH of Capillary blood

942

824

9.41

307.65

6.1

3.7

7.42

0.72

811

685

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2234

2214

11.04

307.65

1.4

1.1

57.04

16.23

iu/ml

15.70

750

614

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

964

839

9.49

307.65

6.1

3.7

5.16

5.10

kpa

0.68

933

792

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1273

2705

3.96

307.65

5.1

5.4

259.42

261.04

u/l

0.09

1223

2596

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1395

667

19.12

307.65

3.1

2.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

930

1528

4.90

307.65

4.3

2.3

206.90

228.33

ng/l

0.53

869

1414

(3019060) Gas panel - Arterial blood

1131

1003

9.62

307.65

4.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

729

314

18.51

307.65

1.9

1.3

—

(3012544) pH of Venous blood

1021

1832

4.54

307.65

5.4

3.1

7.38

0.19

587

1006

(3008152) Bicarbonate [Moles/volume] in Arterial blood

799

1054

6.02

307.65

8.5

6.4

24.95

24.63

mmol/l

1.08

775

999

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

754

318

19.00

307.65

2.4

1.6

—

(3027945) Reticulocytes/Erythrocytes in Blood

1197

2273

4.41

307.65

3.7

2.5

1.93

1.67

10.60

1079

2042

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1916

2092

9.19

307.65

2.7

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

3379

11920

3.45

307.65

5.6

2.7

0.01

0.00

estimate

0.33

934

2273

(3042936) Bacteria identified in Isolate by Culture

1685

2550

6.17

307.65

2.7

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1328

2410

4.74

307.65

8.6

4.9

1.05

1.01

mmol/l

4.35

1254

2241

(3017181) Myelocytes/Leukocytes in Blood

1285

1631

6.85

307.65

7.1

3.7

0.84

1.03

1.21

547

532

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2466

7461

3.33

307.65

5.5

3.4

34.74

38.64

u/l

0.72

2367

7118

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1826

2000

8.97

307.65

2.9

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

351

181

14.41

306.24

2.1

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

345

172

14.89

305.94

2.1

1.9

—

(3021788) Differential panel - Synovial fluid

247

40.13

303.45

1.7

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1243

2768

3.75

300.03

1.9

1.6

1153.29

1116.40

nmol/l

0.58

939

2032

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

294

107

20.23

297.53

1.5

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

817

1317

4.91

296.77

1.4

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

992

1883

4.26

296.34

13.4

7.4

1.45

1.25

mmol/l

3.93

967

1845

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2767

10127

2.79

289.04

3.8

2.4

193.34

150.91

ug/l

6.11

2574

9494

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

853

1461

4.64

288.54

14.4

7.1

25.09

24.77

mmol/l

1.32

846

1452

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

256

27.97

288.15

1.3

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1143

2495

3.77

282.39

1.6

1.5

—

(40758558) Short blood count panel - Blood

2244

7520

2.81

273.14

10.7

6.5

—

(3000991) Gas panel - Venous blood

950

1859

4.10

271.48

15.2

8.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

258

21.96

269.21

1.7

1.2

13488.21

17706.79

e6/l

0.15

183

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

463

464

7.52

264.34

3.3

2.1

324.19

441.05

ug/l

0.57

441

444

(40759836) Histone Ab [Presence] in Serum by Immunoblot

239

26.03

263.57

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

237

26.19

261.87

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

237

26.19

261.87

1.3

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1969

6275

2.84

260.84

7.0

3.8

87.08

89.61

4.07

1936

6170

(3029937) Albumin [Presence] in Urine by Test strip

1928

6089

2.85

259.47

5.6

2.8

0.00

estimate

0.80

895

1986

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

235

25.96

258.99

1.3

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

452

463

7.34

253.32

2.7

4.3

54.10

53.89

mg/l

0.01

348

408

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

231

25.50

253.24

1.3

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

450

462

7.32

251.70

2.7

4.3

43.51

43.26

mg/l

0.01

345

406

(3018333) Ribosomal P Ab [Presence] in Serum

229

25.27

250.37

1.3

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1370

3628

3.17

249.36

1.9

1.4

40249783.48

34383738.54

pmol/l

0.11

1123

3016

(3035933) Granulocytes/Leukocytes in Blood

418

399

7.84

247.76

4.6

3.2

59.16

58.15

0.50

418

399

(3007853) Bacteria identified in Skin by Aerobe culture

970

2066

3.76

245.65

2.1

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

799

1474

4.26

244.96

4.2

2.6

4.56

4.57

kpa

0.01

769

1427

(3011412) CD3 cells [#/volume] in Blood

284

150

13.90

244.36

2.3

1063.73

1182.14

e6/l

0.67

255

132

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

399

367

8.11

243.27

1.4

1.3

—

(3010421) pH of Blood

471

544

6.52

237.88

6.3

2.9

7.42

7.41

0.88

466

536

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

716

1250

4.45

234.58

17.0

9.7

16.01

16.11

0.35

692

1200

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

476

566

6.34

234.07

2.4

3.83

3.84

g/l

0.01

453

512

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

395

377

7.81

233.95

1.4

1.3

39.23

23.76

u/ml

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

476

567

6.33

233.69

2.4

7.72

7.07

g/l

8.72

455

514

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

476

567

6.33

233.69

2.4

4.12

4.10

g/l

0.20

456

514

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

658

1081

4.69

231.61

5.3

3.2

24.35

24.25

mmol/l

0.28

653

1069

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

172

65.33

229.09

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

203

27.77

228.33

2.1

1.4

52352.36

3371.43

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

926

2007

3.67

227.70

4.8

2.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

574

848

5.16

227.37

1.7

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4916

25987

3.52

227.29

38.6

10.2

25.25

30.43

mg/l

23.26

4692

19258

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

272

153

13.02

226.48

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

272

153

13.02

226.48

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

272

153

13.02

226.48

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

403

417

7.21

223.52

2.6

4.2

1.68

5.05

ratio

1.05

188

247

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

418

455

6.86

222.11

7.3

4.4

25.06

24.79

mmol/l

0.76

392

419

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

801

1591

3.94

222.01

5.3

3.4

1.22

1.23

mmol/l

3.04

740

1311

(3011397) Hemoglobin [Presence] in Urine by Test strip

1627

5038

2.77

221.55

4.9

2.6

0.00

0.14

1.42

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

452

540

6.28

221.07

2.4

2.3

3.08

2.98

g/l

0.97

431

486

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1405

4029

2.92

220.05

4.4

2.6

0.83

1.18

e6/l

2.61

755

1903

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2684

10651

2.46

219.96

3.7

2.4

—

estimate

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

167

57.33

218.44

3.6

1.6

42.36

56.94

ug/l

0.51

167

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1365

3873

2.94

217.57

4.7

2.7

1.75

2.23

e6/l

1.03

708

1736

(3044941) Cell count panel - Synovial fluid

198

25.16

216.37

1.7

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

427

491

6.50

216.13

2.4

2.6

0.69

1.46

g/l

1.86

380

418

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

159

71.55

214.17

2.9

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

361

344

7.78

213.82

1.4

1.3

149.31

146.43

au/ml

0.13

103

114

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

443

539

6.16

212.88

1.7

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

980

2308

3.39

212.05

2.4

2.3

0.21

g/l

0.21

917

2182

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

425

498

6.38

211.41

2.4

10.55

10.50

g/l

0.06

400

441

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2322

8774

2.45

208.74

5.5

2.7

0.59

0.31

estimate

0.17

860

1763

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1499

4571

2.76

208.36

2.9

3.9

2.47

2.46

mmol/l

6.44

1366

4110

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

222

16.30

206.49

4.2

3.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

536

814

4.99

205.48

2.4

1.6

1.63

1.51

g/l

1.44

467

687

(3020891) Body temperature

516

767

5.08

202.43

5.6

3.8

36.96

36.87

°c

4.43

509

761

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

386

429

6.69

201.13

2.4

2.5

0.04

0.07

g/l

0.21

354

383

(40768797) Stomach Pathology biopsy report

1074

2779

3.11

198.91

1.4

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

529

818

4.89

198.59

6.4

4.6

1.71

1.63

1.08

506

764

(3027315) Oxygen [Partial pressure] in Blood

354

361

7.26

198.39

7.2

3.1

8.37

8.61

kpa

1.22

349

353

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

229

119

14.00

198.34

2.3

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3848

18503

2.43

196.87

4.6

3.3

14.97

14.66

pmol/l

10.25

3540

16718

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

477

677

5.29

196.46

3.5

2.3

3.84

3.49

g/l

3.80

468

651

(3012501) Base excess in Blood by calculation

351

359

7.23

196.20

7.2

3.1

2.81

2.71

mmol/l

0.20

277

236

(3013290) Carbon dioxide [Partial pressure] in Blood

351

359

7.23

196.20

7.2

3.1

5.04

4.91

kpa

1.54

346

351

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

372

410

6.73

195.17

2.4

2.5

0.00

g/l

-0.00

332

360

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

285

226

9.24

192.84

1.9

1.3

—

(3036489) Thrombin time

475

692

5.15

190.15

3.6

1.9

21.36

21.68

0.33

441

617

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

619

1134

4.17

189.49

4.7

3.0

99.60

81.67

ng/l

3.10

545

971

(3037756) Immunofixation for Serum or Plasma

316

303

7.67

185.95

1.5

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

230

138

12.12

184.70

1.4

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

280

232

8.84

183.69

1.4

1.2

6.04

2.08

u/ml

1.16

128

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1352

4141

2.69

183.45

1.4

1.2

1.23

2.70

u/ml

4.05

349

1075

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

459

674

5.10

182.02

4.1

2.8

0.33

iu/ml

0.08

262

337

(3006571) Granulocytes/Leukocytes in Synovial fluid

144

44.95

180.97

1.7

1.1

57.51

70.97

0.87

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

265

208

9.31

180.46

1.4

1.2

5.34

3.81

u/ml

0.51

163

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

345

384

6.63

179.25

2.5

2.6

0.00

g/l

-0.00

332

360

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

148

36.66

178.55

2.1

1.0

6.08

5.20

u/l

0.60

138

(3007930) Methemoglobin/Hemoglobin.total in Blood

469

738

4.76

172.03

6.9

4.9

0.85

0.88

0.86

447

684

(3042733) HLA Ab [Presence] in Serum

145

33.58

171.48

4.3

4.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1776

6398

2.38

170.03

5.2

2.4

0.06

0.20

estimate

0.43

833

1646

(3014051) Protein [Presence] in Urine by Test strip

1768

6379

2.37

168.39

4.3

2.3

0.03

0.06

0.36

160

(3017569) Oxygen content in Arterial blood

176

16.92

166.75

2.3

2.4

16.33

15.61

0.78

176

(40761536) Microorganisms panel - Urine sediment

746

1712

3.36

165.59

5.6

2.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

350

433

5.97

164.90

1.4

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

439

687

4.77

161.83

3.7

2.1

91.25

87.34

2.42

429

663

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

205

127

11.69

161.58

1.5

1.2

1.76

3.22

u/ml

0.60

141

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

183

14.36

160.90

1.5

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

412

621

4.93

158.35

4.0

2.1

208.45

199.34

0.95

401

589

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

315

364

6.36

158.04

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

315

364

6.36

158.04

1.5

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3115

14452

2.14

157.63

3.3

2.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

558

1086

3.88

156.80

5.2

2.9

126.29

129.02

g/l

1.55

536

1063

(3044640) Blood type and Crossmatch panel - Blood

1940

7476

2.24

156.40

3.4

2.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

301

336

6.57

155.74

1.2

342.59

253.23

u/ml

2.75

193

232

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4432

23799

2.42

154.45

5.9

3.8

2.03

2.01

mu/l

0.25

4121

21472

(3018405) Lactate [Moles/volume] in Arterial blood

362

495

5.40

154.31

4.7

3.7

1.41

1.44

mmol/l

0.14

356

489

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

251

231

7.91

152.21

1.3

1.1

118.95

113.13

1.48

241

204

(4195642) Thrombophilia screening test

249

229

7.92

151.06

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

151

19.03

150.14

45.0

27.3

153.11

125.46

ug/l

2.12

119

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

245

226

7.89

148.28

1.4

1.1

—

(4268621) Lupus anticoagulant assay

204

147

10.04

146.75

2.4

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

177

104

12.27

143.60

2.2

2.5

492.12

521.88

e6/l

0.23

135

(3026250) Tacrolimus [Mass/volume] in Blood

140

20.48

143.13

48.0

30.6

7.97

7.66

ug/l

0.49

127

(3027273) Bicarbonate [Moles/volume] in Venous blood

421

712

4.39

141.28

4.7

2.6

25.64

25.21

mmol/l

1.18

395

689

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

636

1457

3.32

140.53

2.7

2.0

12.37

11.88

ug/l

0.14

565

1308

(3048929) Epstein Barr virus Ab [Presence] in Serum

358

534

4.94

138.90

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

133

20.70

136.53

2.9

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

114

35.39

136.50

1.8

1.2

35.81

22.66

1.15

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

241

244

7.18

135.37

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

142

16.69

133.96

2.2

1.6

31.44

32.66

0.21

142

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

208

177

8.50

133.59

1.2

1.1

96.00

95.80

0.03

203

163

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

431

777

4.12

133.40

5.2

3.1

44.54

45.67

0.34

425

764

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

172

110

11.26

133.00

2.3

2.7

211.56

254.55

e6/l

0.96

148

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

956

2852

2.62

132.39

3.2

2.8

9.66

12.27

umol/l

1.80

839

2592

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

130

18.60

128.26

2.2

1.6

1.78

1.32

ratio

1.64

121

(3014148) Varicella zoster virus Ab [Titer] in Serum

199

169

8.51

127.97

1.1

—

(3047181) Lactate [Moles/volume] in Blood

346

547

4.65

125.53

8.4

5.7

1.38

1.35

mmol/l

0.16

313

483

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

151

12.60

124.51

2.6

2.0

125.61

92.75

ug/min

0.27

(3019550) Sodium [Moles/volume] in Serum or Plasma

4921

28603

2.60

124.09

40.0

12.1

139.11

139.89

mmol/l

72.23

4890

27645

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4540

25475

2.27

123.91

7.8

3.5

40.66

36.60

mmol/mol

142.83

4279

23232

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

449

884

3.78

123.40

4.3

2.5

0.63

0.05

449

879

(3003129) Base excess in Capillary blood by calculation

159

101

11.31

123.40

3.4

2.1

0.91

0.93

mmol/l

0.01

153

(40757373) Influenza virus identified in Isolate

112

24.97

122.38

2.8

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

162

110

10.58

120.84

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

162

110

10.58

120.84

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

162

110

10.58

120.84

1.7

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4922

28715

2.57

120.48

40.4

12.2

4.01

3.96

mmol/l

29.28

4886

27690

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

161

110

10.52

119.63

1.7

1.8

—

(3024932) HLA-DR beta [Type]

125

16.55

117.59

1.0

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3359

17064

1.93

116.66

4.9

2.6

66.19

46.76

u/l

12.96

3178

15880

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1490

5697

2.13

116.25

3.3

2.3

—

(3024471) HLA-A [Type]

126

15.80

116.18

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

203

205

7.15

114.15

2.3

2.4

37.14

22.86

iu/ml

0.56

(3045414) Leukocytes [Presence] in Urine

635

1649

2.91

112.96

2.6

1.9

0.01

0.03

estimate

0.54

169

365

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

170

138

8.86

112.83

1.3

1.2

130.00

62.00

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

170

139

8.80

112.25

1.3

1.1

162.29

243.12

titre

0.31

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

198

202

7.07

110.39

1.1

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4229

23479

2.04

110.01

43.3

13.5

14.26

13.55

162.64

4216

22966

(3045424) Erythrocytes [Presence] in Urine

405

803

3.73

109.96

2.4

2.0

0.10

0.21

estimate

0.23

138

277

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

137

11.82

109.18

1.8

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

137

11.82

109.18

1.8

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

136

11.73

107.94

1.8

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

777

2303

2.58

107.46

2.7

2.6

178.98

143.91

ug/g

1.47

652

1840

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

285

441

4.71

105.77

1.6

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

31.99

105.25

1.3

1.2

41.82

81.27

mg/l

1.59

(3033099) Centromere Ab [Titer] in Serum

29.41

104.17

1.2

1.0

—

(3028433) Virus identified in Specimen by Culture

118

14.28

103.86

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

101

20.55

103.52

1.7

2.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

376

745

3.71

102.04

2.7

1.8

—

(3004809) Band form neutrophils/Leukocytes in Blood

246

344

5.19

102.00

4.3

3.9

1.51

2.31

1.52

234

301

(3019150) Specific gravity of Urine by Refractometry

1258

4769

2.09

98.03

5.4

2.7

1.02

kg/l

0.09

937

2935

(3040151) Glucose [Moles/volume] in Capillary blood

158

141

8.04

97.87

7.0

3.0

7.31

6.24

mmol/l

3.71

137

123

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

278

452

4.48

97.31

1.1

3.78

3.49

0.08

(3009871) Measles virus Ab [Titer] in Serum

119

12.13

96.36

1.4

1.5

2120.00

2448.00

titre

0.14

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

120

11.90

96.12

1.8

1.4

1.08

0.76

nmol/l

2.36

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

213

275

5.60

95.81

1.1

1.56

1.49

g/l

1.48

189

258

(3052851) Hemolysis interference index of Serum or Plasma

304

543

4.08

94.70

4.1

3.0

2.53

2.75

index

0.15

178

284

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

18.77

94.18

1.1

64.85

50.06

iu/ml

—

(3018572) Chloride [Moles/volume] in Blood

256

400

4.65

93.85

8.5

6.6

103.88

104.80

mmol/l

1.87

235

353

(3039000) Anion gap in Blood by calculation

256

400

4.65

93.85

8.5

6.6

11.47

11.03

mmol/l

1.09

235

353

(3000570) Elastase.pancreatic [Mass/mass] in Stool

286

492

4.23

93.42

1.5

1.3

278.74

258.91

ug/g

0.32

168

299

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

297

529

4.09

92.84

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

188

224

6.04

91.35

7.7

5.9

11.88

11.54

mg/l

0.40

172

211

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

295

532

4.04

90.73

1.4

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

298

542

4.01

90.64

1.3

122.27

140.20

titre

0.18

(3000012) Reticulocyte production index

207

277

5.39

89.78

2.8

2.4

0.96

0.85

1.36

157

185

(3034770) Mitochondria Ab [Titer] in Serum

291

532

3.98

87.89

1.2

1.3

1128.67

736.96

titre

0.60

(3025941) Bacteria identified in Stool by Culture

401

925

3.19

86.39

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

236

370

4.62

86.13

2.8

2.4

32.35

40.62

umol/l

3.12

225

339

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

234

371

4.56

84.29

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

262

456

4.17

84.27

1.4

1.3

—

(4015189) Microbial culture of sputum

13.80

84.09

2.2

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

567

1614

2.62

83.99

3.4

2.1

0.50

0.46

e6/l

0.10

546

1550

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4607

27278

1.99

83.10

33.3

11.0

75.68

79.82

ml/min/173m2

34.34

4434

24438

(3010838) Calcium [Moles/time] in 24 hour Urine

202

290

5.02

81.34

1.9

4.41

5.61

mmol/24h

4.39

185

255

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

324

678

3.49

81.02

2.3

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

565

1638

2.57

80.57

3.6

2.5

57.55

67.86

ml/min/173m2

7.57

286

576

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

152

165

6.60

80.32

1.3

1.4

723.20

479.30

mg/l

0.73

141

155

(3011436) Histone Ab [Units/volume] in Serum

30.55

79.76

1.0

—

u/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

715

2327

2.32

79.55

3.0

2.4

36.85

48.12

u/l

1.07

640

2019

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

196

280

5.04

79.34

3.5

2.5

9.34

7.83

pmol/l

1.12

196

280

(40768804) Tissue Pathology biopsy report

2353

11551

1.73

79.28

2.4

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

237

401

4.27

78.92

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

136

133

7.31

78.43

1.3

1.6

—

(3004775) Volume in Urine collected for unspecified duration

16.36

77.87

2.3

1.7

602.86

742.91

1.04

(3034426) Prothrombin time (PT)

14.71

77.81

1.1

1.2

26.64

27.79

0.96

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

379

912

3.05

75.99

3.1

3.0

4.25

4.42

pmol/l

1.89

336

811

(3004451) EKG impression Narrative

101

10.57

75.65

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

300

624

3.50

75.62

3.6

2.8

1.79

1.29

mg/l

16.04

281

574

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

134

137

6.99

74.51

2.4

2.7

38.46

34.86

0.87

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4533

27011

1.89

73.95

5.9

3.8

6.05

5.59

mmol/l

83.92

4162

24624

(3010144) Erythrocytes [#/volume] in Synovial fluid

15.12

73.40

1.6

1.0

127251.42

58994.00

e6/l

0.41

(3044927) Protein electrophoresis panel - Urine

105

8.90

70.34

1.1

—

(4035726) Immunohistochemistry procedure

843

3077

2.08

70.26

1.5

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

132

143

6.59

69.86

1.2

1.5

30.56

8.78

e6/l

0.72

101

(37208534) Antinuclear antibody arbitrary concentration in serum

12.31

69.55

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

100

9.36

69.36

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

134

149

6.42

69.32

1.2

1.4

3.88

3.50

mmol/l

2.80

124

139

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

132

145

6.50

69.02

1.3

1.6

591.07

329.71

e6/l

0.24

108

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

150

191

5.62

68.35

1.3

2.7

—

875.29

—

(3044242) Glucose [Moles/volume] in Arterial blood

102

8.85

68.10

2.0

1.7

8.01

7.06

mmol/l

1.87

102

(3003327) Ova and parasites identified in Stool by Light microscopy

293

648

3.28

67.23

1.9

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4918

30390

2.03

66.89

24.9

8.6

25.43

25.70

u/l

0.53

4875

29180

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4952

30695

2.06

66.37

44.5

13.7

85.93

77.00

umol/l

36.97

4925

30127

(3008757) Leukocyte morphology finding [Identifier] in Blood

148

195

5.43

65.17

4.9

3.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

9.15

64.26

1.1

—

(3024928) Oxygen saturation in Venous blood

244

493

3.58

64.08

4.7

3.1

64.50

62.38

0.65

237

481

(36660697) Celiac disease serology panel - Serum

485

1454

2.46

64.04

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

183

298

4.41

63.80

3.2

3.0

0.89

0.79

nmol/l

1.44

142

233

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

21.57

63.64

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

8.62

63.62

1.2

1.1

1.06

1.07

ratio

0.12

(3016750) Collection duration of Urine

15.02

63.27

2.2

1.8

475.73

493.57

min

0.36

(3022145) Colonoscopy Study observation

776

2858

2.04

62.63

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

145

195

5.32

62.53

1.5

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

255

4.66

61.97

1.1

4.63

2.64

0.50

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

383

1044

2.68

61.18

2.5

2.3

—

(40768443) Skin Pathology biopsy report

389

1070

2.66

61.06

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

350

921

2.77

59.71

1.3

48.04

54.85

au/ml

0.22

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

695

2504

2.08

59.29

1.8

1.6

1.63

1.38

11.50

594

2218

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

374

1026

2.66

58.97

2.5

2.4

34.54

24.03

au/ml

0.82

159

(3047007) Chlamydophila sp Ab [Presence] in Serum

161

253

4.56

58.55

1.3

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

131

172

5.43

57.90

1.8

1.5

4.13

3.23

mg/l

1.24

124

165

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

9.53

57.68

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

246

542

3.28

56.71

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

176

308

4.10

56.13

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

130

175

5.30

56.02

1.3

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

97.77

55.55

1.1

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

9.53

54.89

1.3

1.4

—

(40768446) Kidney Pathology biopsy report

13.91

53.21

1.5

1.8

—

(4146454) Self-monitoring of blood glucose

11.56

53.05

2.6

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

133

197

4.82

51.74

1.2

65.97

60.56

u/l

0.33

118

174

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

127

181

5.00

51.54

1.6

1.3

13.34

11.23

u/l

2.31

120

173

(3020876) Protein [Mass/time] in 24 hour Urine

113

144

5.58

51.47

2.5

2.4

0.85

0.86

g/24h

0.01

(3019225) pH of Specimen

569

2003

2.10

51.21

5.5

3.3

7.37

0.17

466

1353

(3003181) Sodium [Moles/volume] in Urine

171

317

3.86

50.59

1.5

1.3

62.65

59.53

mmol/l

0.39

149

233

(3003434) Protein [Mass/volume] in Pleural fluid

195

405

3.46

49.16

1.5

1.3

33.43

35.45

g/l

1.16

167

370

(3017354) Segmented neutrophils/Leukocytes in Blood

139

225

4.41

48.82

4.4

4.5

57.61

54.57

0.71

128

187

(3008898) HLA-B27 [Presence]

153

269

4.06

48.52

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

106

135

5.58

48.32

1.8

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

182

366

3.56

48.09

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

269

690

2.82

47.98

1.8

1.5

0.35

0.28

mg/l

0.87

134

311

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

149

260

4.09

47.71

1.3

1.2

483.56

695.15

u/l

0.66

139

255

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4320

26406

1.62

47.62

4.8

3.5

1.35

1.19

mmol/l

43.91

3911

24118

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

114

159

5.10

47.36

2.7

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

158

296

3.82

46.09

1.4

1.3

6.59

5.41

mmol/l

4.18

144

277

(3012441) Differential panel - Pleural fluid

164

316

3.71

46.04

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2083

10940

1.53

45.53

5.2

5.7

2.89

4.20

ug/l

0.93

1844

10040

(3000060) B lymphocytes [#/volume] in Blood

10.03

44.42

2.2

1.6

0.88

1.38

e9/l

0.16

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

142

253

4.00

44.28

1.9

1.3

10.75

2.02

iu/l

0.66

(3016018) Differential panel - Cerebral spinal fluid

6.75

43.54

1.3

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

7.27

43.45

1.6

1.4

—

(3007461) Platelets [#/volume] in Blood

4968

31752

1.80

42.52

51.9

15.5

249.34

247.92

e9/l

0.71

4913

30502

(3035941) MCH [Entitic mass]

4969

31773

1.79

42.22

51.6

15.5

30.47

30.38

2.27

4946

31148

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

17.24

42.22

1.7

1.4

0.31

0.56

ug/l

0.77

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4969

31780

1.79

42.06

51.7

15.5

92.41

91.07

64.43

4946

31157

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4969

31782

1.79

42.01

53.8

15.8

39.80

41.81

6.44

4946

31128

(3026361) Erythrocytes [#/volume] in Blood

4969

31785

1.79

41.94

51.8

15.5

4.37

4.54

e12/l

83.94

4898

30381

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4591

28751

1.63

41.93

6.5

4.6

2.52

2.93

mmol/l

170.64

4209

26486

(3010813) Leukocytes [#/volume] in Blood

4969

31789

1.79

41.85

51.8

15.5

7.67

6.44

e9/l

128.72

4902

30373

(3000963) Hemoglobin [Mass/volume] in Blood

4969

31798

1.79

41.63

52.2

15.6

131.62

137.05

g/l

106.51

4947

31177

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.90

41.60

1.6

1.4

—

(3017704) Immunofixation for Urine

7.90

41.41

1.4

1.5

—

(3024263) Appearance of Synovial fluid

11.47

41.03

1.9

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

123

209

4.19

40.75

1.2

15.06

12.90

u/l

0.48

108

199

(3037121) Protein [Mass/volume] in Urine

255

695

2.64

40.56

3.0

4.1

302.78

307.65

mg/l

0.02

133

381

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

9.96

39.90

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

106

162

4.65

39.85

1.2

1.1

100.87

122.75

pmol/l

1.89

106

162

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

9.36

39.74

1.1

90.71

90.00

0.03

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

8.91

39.11

1.1

88.47

91.43

0.18

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

158

333

3.39

38.99

1.2

1.3

43.28

45.61

u/l

0.05

142

287

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

150

307

3.49

38.67

1.1

7.57

13.09

au/ml

0.70

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.78

38.33

4.3

2.5

1.07

1.49

1.14

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

13.22

38.30

1.0

297.40

250.42

mg/l

0.60

(4027681) Cerebrospinal fluid IgG ratio and IgG index

17.17

37.36

1.3

1.2

0.58

0.47

ratio

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

12.20

36.75

1.2

1.0

53.86

30.91

mg/l

1.89

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

14.45

36.43

1.2

1.0

104.84

76.06

ng/l

0.21

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

202

518

2.79

36.04

1.2

1.3

202.22

215.85

miu/ml

0.17

243

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

162

369

3.13

35.43

1.1

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4495

28325

1.55

35.24

5.8

4.1

4.42

4.90

mmol/l

160.78

4127

26234

(40768806) Pleura Pathology biopsy report

150

327

3.27

35.17

1.5

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

113

202

3.98

35.13

1.6

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

6.75

34.95

1.0

1.1

98.41

91.94

1.16

(3005988) Vibrio sp identified in Specimen by Organism specific culture

113

203

3.96

34.91

1.6

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

38.43

34.81

1.1

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4468

28141

1.54

34.77

5.7

4.1

1.41

1.53

mmol/l

62.89

4081

25908

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

7.31

34.41

1.7

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

7.31

34.41

1.7

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

8.31

34.08

1.5

1.0

—

(3045788) Cell count panel - Pleural fluid

145

317

3.26

33.86

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

185

468

2.83

33.84

1.3

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

208

3.86

33.82

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

124

4.86

33.71

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

124

4.86

33.71

1.6

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

186

473

2.81

33.70

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

184

469

2.80

33.20

1.3

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

110

202

3.87

33.03

1.7

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

8.60

32.96

1.1

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

111

206

3.83

32.86

1.7

1.5

—

(3047189) Immunofixation for 24 hour Urine

6.28

32.84

1.7

2.2

—

(3008295) Osmolality of Serum or Plasma

102

179

4.04

32.50

1.4

1.5

271.11

275.91

mosm/kgh2o

0.94

141

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

264

3778

0.46

32.45

2.3

2.0

3.74

3.42

ratio

0.62

217

2988

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

110

205

3.81

32.39

1.7

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

113

4.95

32.02

1.2

1.3

106.83

87.81

u/l

0.41

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

108

5.05

31.87

1.2

1.4

47.62

20.54

u/l

1.08

(3023199) Leukocytes [#/volume] in Pleural fluid

155

370

2.99

31.39

1.5

1.4

5311.42

3403.53

e6/l

0.26

255

(3020961) Endomysium IgA Ab [Titer] in Serum

265

831

2.29

31.35

1.1

301.00

202.58

titre

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.46

31.29

1.8

1.5

8.69

10.28

ug/l

0.77

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

10.84

30.58

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

8.53

30.17

2.0

2.7

68.92

100.43

u/l

0.19

(21494434) Karyotype in Bone marrow

106

203

3.71

30.09

1.4

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

10.17

28.72

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

195

2966

0.44

28.07

1.3

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

5.04

27.76

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

739

3378

1.61

27.73

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.95

27.68

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.41

27.65

6.8

3.6

69.62

72.31

mg/l

0.07

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

165

3.86

27.14

1.3

—

(3023410) Appearance of Cerebral spinal fluid

5.43

26.90

1.3

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

118

4.43

26.58

1.5

8.15

6.11

u/l

0.45

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

100

202

3.51

26.37

2.9

1.8

28.80

31.77

mg/l

0.17

(3050794) Legionella sp Ab [Presence] in Serum

14.07

26.31

1.1

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

179

2743

0.44

26.20

2.1

1.8

3.36

3.57

mmol/l

1.50

134

1930

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

108

4.58

26.13

1.2

1.1

32.39

17.64

u/l

1.26

(3019832) Treponema pallidum Ab [Presence] in Serum

345

1289

1.93

25.92

1.5

1.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

109

4.54

25.86

1.2

1.1

88.06

81.96

u/l

0.23

(3039744) RNA polymerase III Ab [Units/volume] in Serum

29.73

25.73

1.0

5.50

—

u/ml

—

(3035880) pH of Pleural fluid

146

3.97

25.71

1.3

1.2

7.39

7.41

0.30

101

(3051611) Lipemic interference index of Serum or Plasma

106

227

3.31

25.63

5.3

3.0

14.78

12.48

index

1.31

147

(3049717) Cytology report of Urine Cyto stain

288

1017

2.04

25.36

2.9

3.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

106

230

3.27

25.13

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

135

341

2.81

24.83

1.5

1.4

180742.73

33689.17

e6/l

1.48

203

(3022621) pH of Urine by Test strip

416

1674

1.80

24.82

3.9

2.0

6.14

6.06

0.93

325

1100

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

7.60

24.73

5.0

1.3

211.68

127.25

umol/l

0.40

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.83

24.67

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

221

712

2.22

24.56

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2043

11650

1.36

23.89

2.2

1.7

1.42

1.26

mmol/l

16.07

1671

9774

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

7.04

23.87

1.4

1.0

—

(4024509) Urine culture

243

828

2.10

23.51

2.3

1.6

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

5.07

23.42

1.4

1.3

64.89

60.24

0.30

(3001893) Eosinophils/Leukocytes in Pleural fluid

5.53

23.34

1.4

1.3

2.37

2.93

0.15

(3003694) ABO and Rh group [Type] in Blood

1453

7868

1.39

23.27

1.5

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

759

3642

1.53

22.80

3.4

5.6

23.95

49.94

ug/l

1.01

642

3000

(3006922) Hepatitis E virus Ab [Presence] in Serum

152

3.68

22.37

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

135

3.82

21.82

1.1

—

(3020491) Glucose [Moles/volume] in Blood

113

4.12

21.80

2.0

1.5

7.61

6.01

mmol/l

4.13

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

158

463

2.43

21.77

1.1

16.92

9.98

eliau/ml

0.40

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

11.86

21.71

1.2

1.3

285723.62

572733.12

nmol/l

0.18

(1002224) Polysomnography panel

206

685

2.15

21.22

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

122

3.94

21.17

1.0

1.1

290.47

290.31

mg/l

0.01

111

(40768795) Lymph node Pathology biopsy report

128

344

2.64

21.03

1.5

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

6.40

21.00

2.8

4.8

6.61

9.80

mg/l

1.30

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

7.48

20.28

1.4

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.10

19.84

2.4

2.5

0.63

0.62

mmol/l

0.22

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

7.49

19.72

1.1

1.2

79.31

55.86

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

5.77

19.61

1.3

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

7.25

19.24

1.0

1.2

86.85

68.38

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

6.66

19.02

1.3

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.91

18.69

5.8

7.9

6.14

6.02

kpa

0.24

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

4.60

18.54

1.1

1.0

15.60

3.33

u/ml

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

6.18

18.34

1.4

1.2

24.66

22.68

0.10

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

100

255

2.78

18.18

1.4

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

232

857

1.93

18.04

1.4

1.5

—

(3000330) Specific gravity of Urine by Test strip

261

1005

1.86

17.91

4.3

2.7

1.02

ratio

0.01

247

911

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

170

3.20

17.87

1.1

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

132

3.53

17.77

1.4

1.5

13.00

21.96

u/ml

—

(3016038) Potassium [Moles/volume] in Urine

124

3.59

17.36

1.3

1.1

35.19

37.57

mmol/l

0.31

111

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.46

17.25

3.4

1.6

9.55

10.88

kpa

1.86

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.46

17.25

3.4

1.6

4.71

4.68

kpa

0.06

(3035637) Corticotropin [Mass/volume] in Plasma

105

285

2.61

16.99

1.5

29.86

35.08

ng/l

0.21

105

285

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

120

3.59

16.83

1.9

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

3.93

16.59

1.4

1.2

1.22

1.60

promille

0.88

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.31

16.36

1.2

1.1

1.92

2.04

mmol/l

0.17

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

226

2.78

16.34

1.3

1.4

314.68

335.38

pmol/l

0.15

194

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

311

1299

1.72

16.29

1.2

1.1

139.15

151.58

u/ml

0.20

500

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.99

16.17

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

6.08

16.10

1.4

1.3

4.36

14.83

1.61

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.80

16.06

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1569

9002

1.30

15.99

4.4

4.3

21.91

21.34

0.68

730

4779

(3032743) Legionella sp IgG Ab [Presence] in Serum

18.28

15.65

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

18.28

15.65

1.7

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

125

3.39

15.27

1.2

—

(44813793) Dust mix specific IgE antibody measurement

119

3.44

15.10

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

278

2.52

15.02

1.4

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

148

3.15

15.00

5.2

7.1

334.50

394.31

umol/l

2.22

124

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

221

2.72

14.98

1.5

1.3

0.70

0.65

nmol/l

0.38

212

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

135

439

2.18

14.80

1.2

1.1

1.20

2.00

u/ml

0.57

233

(3035320) C reactive protein [Mass/volume] in Body fluid

157

3.06

14.75

3.3

2.2

27.71

31.76

mg/l

0.36

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

199

748

1.89

14.75

1.6

1.7

19.46

20.19

u/ml

0.04

211

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1155

0.36

14.75

1.1

0.62

ratio

0.00

175

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

7.32

14.70

1.3

1.0

299.63

33.78

u/l

0.62

(3020717) Zinc [Moles/volume] in Serum or Plasma

3.89

14.58

2.4

1.3

19.32

26.53

umol/l

0.73

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

8.58

14.53

1.1

1.0

123.14

82.40

nmol/l

0.70

(3011985) Renin [Units/volume] in Plasma

246

2.59

14.43

1.3

1.5

56.27

59.18

mu/l

0.05

220

(3014271) Vancomycin [Susceptibility]

5.09

14.42

2.9

2.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

195

2.79

14.26

1.5

1.3

0.19

nmol/l

0.05

163

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

223

2.66

14.25

1.5

1.3

0.14

0.15

nmol/l

—

(3006576) Bicarbonate [Moles/volume] in Blood

4.02

14.24

5.3

7.9

25.13

25.20

mmol/l

0.03

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

4.33

14.18

1.3

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

16.86

14.13

1.6

1.3

1.06

4.88

mg/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

4.46

13.94

5.6

6.4

5.61

5.16

kpa

0.58

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

148

3.05

13.87

1.0

1.1

9.02

9.40

iu/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.11

13.65

1.4

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

5.19

13.43

2.3

1.6

37.87

39.89

g/l

0.89

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

16.16

13.37

1.6

1.3

2.81

1.15

mg/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

152

2.97

13.28

1.2

10.82

17.42

u/ml

—

(3000034) Microalbumin [Mass/volume] in Urine

3.52

13.01

2.5

1.7

45.35

29.21

mg/l

0.28

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.27

12.91

1.1

1396.28

1429.66

miu/ml

0.05

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

179

2.76

12.78

1.5

1.3

—

nmol/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1203

0.42

12.56

1.2

1.53

1.55

g/l

0.22

1203

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

7.02

12.53

1.0

—

(44806071) Cardiolipin IgM antibody measurement

12.05

12.48

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.37

12.42

1.2

1.0

0.04

1.44

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

111

359

2.19

12.40

1.1

1.33

1.26

u/ml

0.04

186

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.42

12.24

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

6.46

12.24

2.1

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.59

12.18

1.3

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

11.24

12.12

1.2

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

100

314

2.25

11.99

1.1

2.56

2.97

u/ml

0.14

157

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

3.23

11.95

2.4

1.7

—

(3002256) Pathology report gross observation

761

4089

1.35

11.86

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.69

11.69

2.3

2.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.76

11.62

1.2

122.27

345.58

ug/l

0.61

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

6.70

11.52

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

16.67

11.26

11.6

10.8

5.42

4.61

mmol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

12.29

11.09

1.4

2.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.86

10.97

1.3

1.0

0.52

0.95

mmol/l

0.39

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

172

2.62

10.71

1.8

1.7

1.47

1.59

u/field

0.09

(3009214) Lutropin [Units/volume] in Serum or Plasma

122

434

1.99

10.71

1.5

10.42

12.02

u/l

0.56

351

(3006653) Thiamine [Moles/volume] in Blood

5.27

10.59

1.1

1.5

119.75

131.22

nmol/l

0.41

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.72

10.52

1.2

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

305

2.18

10.48

1.1

1.32

3.23

u/ml

1.32

135

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

168

669

1.78

10.48

3.2

4.5

92.49

1411.11

u/ml

1.62

150

608

(40765096) Chromosome analysis panel by Banding

3.43

10.26

1.2

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

3.87

10.25

1.5

1.3

23.04

20.55

0.15

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.52

10.17

1.0

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.25

10.12

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

5.21

10.05

1.8

1.0

16.74

16.64

umol/l

0.02

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

9.22

9.75

1.1

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

108

383

1.99

9.61

1.1

3.11

3.86

u/ml

0.24

207

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

482

2491

1.39

9.54

9.4

5.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

13.26

9.36

1.2

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

4.39

9.10

1.3

1.1

9.87

10.63

pmol/l

0.06

(3018851) Theophylline [Moles/volume] in Serum or Plasma

9.52

9.02

1.9

1.6

46.42

45.07

umol/l

0.06

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

261

2.16

8.87

1.1

1.0

0.17

0.57

u/ml

0.52

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

248

2.19

8.81

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

221

999

1.57

8.62

1.1

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.68

8.61

1.3

1.8

46.52

22.35

pmol/l

1.14

(4034850) Laboratory test

166

701

1.68

8.50

14.1

6.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

102

372

1.94

8.44

1.1

0.73

1.15

u/ml

0.44

182

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

4.08

8.36

1.6

1.2

15.79

13.56

pmol/l

0.93

(3013139) Helicobacter pylori Ag [Presence] in Stool

298

1459

1.45

8.00

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

561

3059

1.32

7.82

5.1

4.0

32.12

31.93

0.16

418

1761

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.51

7.70

1.3

0.34

0.27

g/l

2.49

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

5.05

7.65

1.2

1.1

355.05

0.42

mg/l

0.47

(3052592) Norovirus Ag [Presence] in Stool

7.43

7.53

2.2

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1179

7046

1.22

7.53

3.2

0.70

0.88

ug/l

7.96

830

4587

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3680

24243

1.18

7.51

44.3

13.5

329.46

332.76

g/l

82.80

3667

24062

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

3.51

7.44

1.1

1.0

38.99

31.02

ng/l

0.31

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.95

7.42

1.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

7.95

7.42

1.2

1.0

6.60

5.67

iu/ml

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

7.95

7.42

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

8.64

7.33

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.93

7.29

1.3

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

7.02

7.29

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

3.45

7.25

1.1

1.0

853.39

824.06

ng/l

0.11

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.46

7.16

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

3.39

7.07

1.6

12.27

2.88

nmol/l

0.53

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.76

6.95

1.4

1.3

—

iu/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

14.03

6.89

1.0

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

3.38

6.80

1.1

1.0

348.82

289.69

ng/l

0.32

(3006270) Folate [Moles/volume] in Blood

138

2.40

6.72

1.1

342.69

377.67

nmol/l

0.45

128

(3008402) Methanol [Moles/volume] in Serum or Plasma

8.09

6.68

1.1

—

mmol/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.88

6.63

1.5

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.88

6.63

1.5

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.88

6.63

1.5

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

7.02

6.54

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

10.13

6.53

6.2

4.4

108.69

105.78

g/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

12.02

6.51

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.07

6.35

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

120

505

1.68

6.33

5.0

3.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

112

2.51

6.32

3.3

2.5

221.65

201.18

u/l

0.89

112

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.42

6.28

3.1

2.7

0.69

0.82

mg/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.02

6.17

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.78

6.13

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.30

6.10

5.0

6.7

11.11

10.52

0.68

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

4.07

6.05

1.5

1.3

—

(40768441) Liver Pathology biopsy report

205

2.06

6.05

1.5

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

119

2.42

6.04

1.8

1.5

1.79

7.45

u/field

0.71

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.49

6.02

1.8

4.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

6.58

5.94

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

111

466

1.68

5.93

1.3

1.8

306.64

314.35

mu/l

0.09

425

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

11.02

5.80

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

277

1.88

5.80

1.0

1.1

12.53

3.94

eliau/ml

0.65

143

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

4.32

5.77

1.1

1.0

1084.17

92.62

ng/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.60

5.65

1.6

1.5

121.22

84.08

ng/l

1.08

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

480

0.41

5.63

1.6

1.5

1181.82

1107.97

mu/l

0.12

383

(40758292) HTLV I+II Ab panel - Serum

3.51

5.56

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

467

2616

1.27

5.32

2.8

2.0

13.03

14.24

nmol/l

2.60

419

2404

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.10

5.30

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

5.10

5.30

1.9

4.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.65

5.29

1.8

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.51

5.19

2.3

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

10.01

5.11

1.5

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

12.62

5.09

1.3

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.90

5.02

1.8

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.51

5.02

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.03

4.93

1.1

1233.33

870.00

titre

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

345

1.71

4.93

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.74

4.86

1.1

19.00

19.16

u/l

—

(1761868) Lipid panel - Serum or Plasma

1508

11668

0.87

4.84

3.7

2.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

10.51

4.74

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

10.51

4.74

1.0

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

7.01

4.67

1.3

1.1

57.73

78.73

ug/l

1.30

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.62

4.66

1.4

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

188

1.94

4.59

2.3

2.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.41

4.56

1.2

1.3

266.36

320.07

pmol/l

0.19

(3015350) Toxocara sp Ab [Presence] in Serum

+∞

4.52

1.0

0.0

—

(3020650) Glucose [Presence] in Urine

2.45

4.47

1.9

1.2

0.00

estimate

-0.00

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.68

4.40

1.5

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.39

4.40

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

111

2.21

4.33

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

7.01

4.29

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.01

4.29

1.5

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

4.46

4.24

1.5

1.9

1.22

1.18

mmol/l

0.84

(3038177) Helicobacter pylori Ab [Presence] in Serum

350

1.65

4.23

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.93

4.22

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

4.80

4.21

1.5

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

5.26

4.20

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.26

4.20

2.3

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.08

4.18

1.2

1.4

105.61

115.96

nmol/24h

0.09

(3006442) Creatine [Moles/volume] in Serum or Plasma

141

2.04

4.17

1.9

1.4

93.34

89.94

umol/l

0.16

141

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.96

4.15

2.5

2.2

4.81

54.16

ug/l

0.61

(3044009) aPTT.lupus sensitive (LA screen)

9.34

4.05

1.4

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.34

4.05

1.0

1.2

—

(4212803) Bone marrow aspirate examination

4.95

4.02

1.2

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.75

3.87

1.1

1.0

14.95

10.31

u/ml

0.25

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

8.01

3.77

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

8.01

3.77

1.0

1.7

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

4.14

3.74

2.0

1.8

1.22

1.19

mmol/l

0.72

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

9.81

3.67

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

9.81

3.67

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

9.81

3.67

8.7

1.2

8.29

6.24

mmol/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

244

1326

1.30

3.61

3.2

4.4

10795.13

2053.25

u/ml

0.38

207

1164

(3002079) Sodium [Moles/time] in 24 hour Urine

2.45

3.58

1.4

1.3

140.70

171.26

mmol/24h

0.99

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.21

3.54

1.2

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

309

0.43

3.50

1.3

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

141

709

1.40

3.47

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

5.73

3.47

1.0

78.22

87.27

titre

—

(3026480) Teichoate Ab [Titer] in Serum

5.73

3.47

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.01

3.47

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

437

1.51

3.46

1.2

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.17

3.39

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

435

1.50

3.34

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.28

3.34

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.65

3.34

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

366

1.54

3.20

2.1

2.2

4250.32

8888.92

u/l

0.63

158

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.31

3.19

1.3

1.1

15.17

12.73

g/l

0.57

(3001019) Free T4 and TSH panel - Serum or Plasma

118

1145

0.72

3.17

1.7

1.6

—

(3019174) dRVVT (LA screen)

7.01

3.14

1.4

1.1

—

(3006462) Nitrate [Presence] in Urine

2.13

3.13

4.9

2.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

273

0.43

3.08

1.5

1.4

1.62

1.11

ratio

—

168

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

273

0.43

3.08

1.5

1.4

0.95

ratio

—

168

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

273

0.43

3.08

1.5

1.4

1.51

1.20

ratio

—

168

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

291

0.46

3.04

1.5

66.91

58.85

ug/l

0.13

235

(3034274) Bile acid [Moles/volume] in Serum --fasting

129

1.90

3.03

1.1

2.1

6.26

9.36

umol/l

0.76

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

110

544

1.42

3.02

2.1

1.7

188.64

221.46

pmol/l

3.35

101

515

(4211845) Urine protein measurement

100

2.04

3.01

4.6

2.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

270

0.44

3.00

1.5

1.4

—

(3016135) IgD [Mass/volume] in Serum

8.41

3.00

1.3

1.0

204.83

24.82

mg/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

8.41

3.00

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.51

2.94

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.13

2.91

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.13

2.91

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

157

0.36

2.87

1.6

1.5

58.20

57.73

ug/l

—

157

(3014891) Appearance of Pleural fluid

2.70

2.85

1.9

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

713

0.66

2.83

1.6

1.7

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

3.24

2.77

2.7

2.1

67.43

51.56

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.01

2.75

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

7.01

2.75

1.2

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.45

2.71

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

219

0.41

2.69

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.35

2.68

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

253

1.58

2.65

1.2

7.05

6.56

mmol/l

0.77

208

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.94

2.64

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

246

0.45

2.63

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

1.71

2.59

1.3

1.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

3.34

2.47

2.4

2.1

2.20

31.92

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

237

0.47

2.41

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.06

2.40

1.1

1.2

24.09

27.82

g/l

0.56

(3040893) Potassium [Moles/volume] in Capillary blood

7.01

2.35

3.2

1.2

4.46

4.70

mmol/l

—

(40762887) Creatinine [Moles/volume] in Blood

5.25

2.33

1.7

1.6

—

(3005033) Fetal Nuchal fold Thickness US

233

0.48

2.31

1.4

1.22

1.29

—

159

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.25

2.30

1.1

1.2

1.11

62.46

u/ml

0.51

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.86

2.26

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.86

2.26

1.6

1.8

0.55

0.44

u/field

0.13

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.05

2.25

1.1

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.67

2.16

1.3

3.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.92

2.15

1.5

1.0

0.74

0.69

umol/24h

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.84

2.14

1.0

0.03

0.08

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

105

552

1.34

2.11

6.3

2.4

27.26

29.37

mg/l

0.25

372

(3023511) Choriogonadotropin [Units/volume] in Urine

163

1.64

2.09

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

110

1.79

2.08

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.77

2.08

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.34

2.07

1.9

2.8

1.18

0.87

ug/l

0.36

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.50

1.95

1.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

3.11

1.94

1.4

1.2

446.50

1115.28

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

190

0.48

1.94

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.82

1.86

11.3

8.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.41

1.74

1.4

1.6

1.19

mmol/l

0.00

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

2.41

1.74

2.2

1.9

38.68

52.91

pmol/l

0.77

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.50

1.73

1.0

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.79

1.70

1.4

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

2.34

1.65

1.2

1.6

467.36

540.82

mu/l

0.17

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

591

0.73

1.65

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.89

1.64

1.0

8.80

10.22

u/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

130

732

1.25

1.62

1.6

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

125

0.45

1.61

1.4

1.2

—

(4198724) Urine methamphetamine measurement

1.98

1.56

1.1

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.89

1.55

1.8

1.9

—

(3002619) Bacteria identified in Specimen by Culture

2.16

1.52

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.50

1.51

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.00

1.49

1.1

1.0

21.83

36.49

iu/ml

0.75

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.80

1.41

1.0

1.1

0.01

0.24

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

809

0.79

1.39

2.1

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

148

1.52

1.38

1.3

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.65

1.29

1.1

23.71

9.54

mm/h

1.97

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.92

1.29

2.2

1.1

1.80

1.46

umol/24h

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

2.12

1.24

1.2

1.6

78.80

69.03

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.62

1.20

1.2

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

658

0.80

1.16

1.9

2.0

—

(4281824) Cell count and differential, peritoneal fluid

475

0.76

1.12

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

206

1.36

1.04

3.4

6.8

123.83

112.45

u/ml

0.05

(3023323) Follitropin [Units/volume] in Serum or Plasma

144

864

1.17

1.04

1.4

33.95

37.01

iu/l

0.43

112

723

(1001926) Buprenorphine [Presence] in Urine by Screen method

454

1.24

1.03

1.9

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

224

1398

1.13

0.95

1.7

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.21

0.93

2.3

3.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

127

1.44

0.93

1.7

1.4

522.81

1310.22

e6/l

1.37

(40768800) Prostate Pathology biopsy report

133

1074

0.86

0.90

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.10

0.89

1.2

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

247

1567

1.11

0.82

1.8

1.9

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

248

1.27

0.79

2.0

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.83

0.78

3.3

2.7

—

(44806420) Estimation of glomerular filtration rate

212

1.29

0.76

2.9

2.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

370

1.21

0.75

6.6

1.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.06

0.73

1.0

9.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

288

0.78

0.69

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.84

0.67

1.4

1.1

6.34

6.15

mmol/l

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.53

0.61

2.9

8.2

38.83

38.42

u/l

0.02

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.50

0.51

1.2

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

226

1.21

0.50

1.2

1.4

35.05

38.64

u/l

0.25

198

(40768793) Breast Pathology biopsy report

127

805

1.11

0.50

1.4

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

207

0.81

0.42

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.33

0.41

2.0

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

155

1.22

0.40

3.7

8.1

10.90

20.80

ug/l

0.51

103

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

128

968

0.92

0.36

1.5

1.4

—

(4133840) Spirometry

1.31

0.31

1.3

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.29

0.30

1.0

—

(3016879) Cocaine [Presence] in Urine

588

1.08

0.29

1.8

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

143

1.18

0.27

1.0

1.1

0.82

3.11

u/ml

0.78

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

216

0.87

0.24

1.4

1.2

150.28

195.35

pmol/l

1.46

216

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

148

1091

0.95

0.24

2.2

1.6

21.17

3.03

mg/l

6.58

132

725

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(4038314) Semen analysis, post vasectomy

0.00

0.22

0.0

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.22

0.0

1.1

—

1.29

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

219.13

—

(3027008) Opiates [Presence] in Urine

650

1.06

0.18

1.8

1.5

—

(3028300) Cannabinoids [Presence] in Urine

652

1.05

0.17

1.8

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

546

3894

0.98

0.17

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

110

1.15

0.16

1.4

28412.20

6155.58

e6/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

125

1.12

0.14

1.1

1.09

0.53

u/ml

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.09

0.08

1.0

1.5

0.05

1.26

u/ml

—

(3027944) Amphetamines [Presence] in Urine

646

1.03

0.08

1.8

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

648

1.03

0.07

1.8

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

137

1.07

0.07

1.0

1.2

0.61

3.04

u/ml

1.74

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

151

1.07

0.06

22.9

18.6

1392.61

1442.55

nmol/l

0.13

139

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

301

2130

0.99

0.06

1.4

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

214

1517

0.99

0.05

3.3

5.2

47.73

85.52

u/ml

1.85

208

1488

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

266

1.03

0.02

1.9

1.5

0.19

0.30

nmol/l

1.76

193

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

144

1.02

0.00

17.4

13.8

797.14

895.32

nmol/l

0.43

136

(3025130) Human papilloma virus identified in Specimen

373

0.99

0.00

1.8

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.05

0.00

2.5

2.2

0.33

1.37

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.02

-0.00

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.87

-0.00

2.0

1.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: IBD_PULM – Respiratory diseases principally affecting the interstitium, IBD co-morbidites

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Respiratory diseases principally affecting the interstitium, IBD co-morbidites (IBD_PULM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints